{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:16:13Z","timestamp":1790090173187,"version":"4.0.1"},"reference-count":252,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["National Institute on Aging"],"award-info":[{"award-number":["National Institute on Aging"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lewy body disorders (LBD) are a spectrum of neurodegenerative diseases characterized by the presence of misfolded neuronal alpha-synuclein (aSYN) pathology in the central and peripheral nervous system. LBDs have heterogeneous clinical presentations, which include dementia with Lewy bodies (DLB), Parkinson\u2019s disease (PD), and PD with dementia (PDD). Thus, LBD clinical syndromes (PD\/PD\/DLB) represent clinicopathologic entities (i.e. constellations of symptoms and supportive biomarkers with a high specificity for underlying aSYN pathology), but clinical features between PDD and DLB largely overlap. Indeed, there is longstanding debate over the utility of the clinical designation between PDD and DLB due to shared underlying pathology, genetic risk factors and prodromal features. Recent advances in the ability to detect pathological aSYN from peripheral fluids\/tissues in living patients has ushered in a new era of biological classification of LBD, providing opportunity to improve antemortem diagnosis and facilitate disease-modifying therapeutic trials. The clinical interpretation of these and future aSYN-specific biological tests will be complex, and the reconciliation of classic LBD syndromes with emerging biological classification schemes for LBD and other neurodegenerative disorders is a priority. Indeed, varying burden of aSYN is also found postmortem in &gt;\u200950% of clinical Alzheimer\u2019s disease (AD), and to a lesser frequency as co-pathology in other neurodegenerative disorders, and incidentally in adults without neurologic disease. This review summarizes autopsy-confirmed data on the clinical expression of LBDs and the boundaries between PDD, DLB and mixed-pathology AD to inform the interpretation of emerging biological tests for aSYN and biological classification schemes for LBD and AD.<\/jats:p>","DOI":"10.1007\/s00702-025-03060-5","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T10:19:28Z","timestamp":1764843568000},"page":"193-214","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Where do PDD and DLB SYNdromes fit in neuronal alpha-SYNuclein biological frameworks?"],"prefix":"10.1007","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5599-5098","authenticated-orcid":false,"given":"David J.","family":"Irwin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"issue":"3","key":"3060_CR1","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1750-3639.2009.00369.x","volume":"20","author":"D Aarsland","year":"2010","unstructured":"Aarsland D, Kurz MW (2010) The epidemiology of dementia associated with Parkinson\u2019s disease. Brain Pathol 20(3):633\u2013639. https:\/\/doi.org\/10.1111\/j.1750-3639.2009.00369.x","journal-title":"Brain Pathol"},{"issue":"3","key":"3060_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1001\/archneur.60.3.387","volume":"60","author":"D Aarsland","year":"2003","unstructured":"Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P (2003) Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 60(3):387\u2013392","journal-title":"Arch Neurol"},{"issue":"10","key":"3060_CR3","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/jnen\/nlz080","volume":"78","author":"CH Adler","year":"2019","unstructured":"Adler CH, Beach TG, Zhang N, Shill HA, Driver-Dunckley E, Caviness JN, Mehta SH, Sabbagh MN, Serrano GE, Sue LI, Belden CM, Powell J, Jacobson SA, Zamrini E, Shprecher D, Davis KJ, Dugger BN, Hentz JG (2019) Unified staging system for lewy body disorders: clinicopathologic correlations and comparison to Braak staging. J Neuropathol Exp Neurol 78(10):891\u2013899. https:\/\/doi.org\/10.1093\/jnen\/nlz080","journal-title":"J Neuropathol Exp Neurol"},{"issue":"9","key":"3060_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-025-13360-1","volume":"272","author":"FC Almeida","year":"2025","unstructured":"Almeida FC, Santos A, Jesus T, Gauthreaux K, Mock CN, Kukull WA, Crary JF, Oliveira TG (2025) Amygdala-predominant lewy bodies associate with cognitive decline and amygdala atrophy in Alzheimer\u2019s disease neuropathological change. J Neurol 272(9):629. https:\/\/doi.org\/10.1007\/s00415-025-13360-1","journal-title":"J Neurol"},{"issue":"8","key":"3060_CR5","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/mds.20897","volume":"21","author":"G Alves","year":"2006","unstructured":"Alves G, Larsen JP, Emre M, Wentzel-Larsen T, Aarsland D (2006) Changes in motor subtype and risk for incident dementia in Parkinson\u2019s disease. Mov Disord 21(8):1123\u20131130. https:\/\/doi.org\/10.1002\/mds.20897","journal-title":"Mov Disord"},{"issue":"5","key":"3060_CR6","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41593-025-01910-9","volume":"28","author":"KB Andersen","year":"2025","unstructured":"Andersen KB, Krishnamurthy A, Just MK, Van Den Berge N, Skjaerbaek C, Horsager J, Knudsen K, Vogel JW, Toledo JB, Attems J, Polvikoski T, Saito Y, Murayama S, Borghammer P (2025) Sympathetic and parasympathetic subtypes of body-first lewy body disease observed in postmortem tissue from prediagnostic individuals. Nat Neurosci 28(5):925\u2013936. https:\/\/doi.org\/10.1038\/s41593-025-01910-9","journal-title":"Nat Neurosci"},{"issue":"3","key":"3060_CR7","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/acn3.51988","volume":"11","author":"S Arezoumandan","year":"2024","unstructured":"Arezoumandan S, Cousins KAQ, Ohm DT, Lowe M, Chen M, Gee J, Phillips JS, McMillan CT, Luk KC, Deik A, Spindler MA, Tropea TF, Weintraub D, Wolk DA, Grossman M, Lee V, Chen-Plotkin AS, Lee EB, Irwin DJ (2024) Tau maturation in the clinicopathological spectrum of lewy body and Alzheimer\u2019s disease. Ann Clin Transl Neurol 11(3):673\u2013685. https:\/\/doi.org\/10.1002\/acn3.51988","journal-title":"Ann Clin Transl Neurol"},{"issue":"7","key":"3060_CR8","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/S1474-4422(24)00211-4","volume":"23","author":"D Arnaldi","year":"2024","unstructured":"Arnaldi D, Pardini M, Chincarini A, Garibotto V, Morbelli S (2024) Concerns with the new biological research criteria for synucleinopathy. Lancet Neurol 23(7):662\u2013663. https:\/\/doi.org\/10.1016\/S1474-4422(24)00211-4","journal-title":"Lancet Neurol"},{"issue":"4","key":"3060_CR9","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/ana.26453","volume":"92","author":"MR Arnold","year":"2022","unstructured":"Arnold MR, Coughlin DG, Brumbach BH, Smirnov DS, Concha-Marambio L, Farris CM, Ma Y, Kim Y, Wilson EN, Kaye JA, Hiniker A, Woltjer RL, Galasko DR, Quinn JF (2022) alpha-Synuclein seed amplification in CSF and brain from patients with different brain distributions of pathological alpha-Synuclein in the context of Co-Pathology and Non-LBD diagnoses. Ann Neurol 92(4):650\u2013662. https:\/\/doi.org\/10.1002\/ana.26453","journal-title":"Ann Neurol"},{"issue":"2","key":"3060_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00401-020-02255-2","volume":"141","author":"J Attems","year":"2021","unstructured":"Attems J, Toledo JB, Walker L, Gelpi E, Gentleman S, Halliday G, Hortobagyi T, Jellinger K, Kovacs GG, Lee EB, Love S, McAleese KE, Nelson PT, Neumann M, Parkkinen L, Polvikoski T, Sikorska B, Smith C, Grinberg LT, Thal DR, Trojanowski JQ, McKeith IG (2021) Neuropathological consensus criteria for the evaluation of lewy pathology in post-mortem brains: a multi-centre study. Acta Neuropathol 141(2):159\u2013172. https:\/\/doi.org\/10.1007\/s00401-020-02255-2","journal-title":"Acta Neuropathol"},{"key":"3060_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-015-0209-z","volume":"3","author":"AD Bachstetter","year":"2015","unstructured":"Bachstetter AD, Van Eldik LJ, Schmitt FA, Neltner JH, Ighodaro ET, Webster SJ, Patel E, Abner EL, Kryscio RJ, Nelson PT (2015) Disease-related microglia heterogeneity in the hippocampus of Alzheimer\u2019s disease, dementia with Lewy bodies, and hippocampal sclerosis of aging. Acta Neuropathol Commun 3:32. https:\/\/doi.org\/10.1186\/s40478-015-0209-z","journal-title":"Acta Neuropathol Commun"},{"issue":"11","key":"3060_CR12","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1212\/01.wnl.0000249130.63615.cc","volume":"67","author":"C Ballard","year":"2006","unstructured":"Ballard C, Ziabreva I, Perry R, Larsen JP, O\u2019Brien J, McKeith I, Perry E, Aarsland D (2006) Differences in neuropathologic characteristics across the lewy body dementia spectrum. Neurology 67(11):1931\u20131934. https:\/\/doi.org\/10.1212\/01.wnl.0000249130.63615.cc","journal-title":"Neurology"},{"issue":"10","key":"3060_CR13","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1093\/brain\/awae203","volume":"147","author":"L Barba","year":"2024","unstructured":"Barba L, Abu-Rumeileh S, Barthel H, Massa F, Foschi M, Bellomo G, Gaetani L, Thal DR, Parnetti L, Otto M (2024) Clinical and diagnostic implications of Alzheimer\u2019s disease copathology in lewy body disease. Brain 147(10):3325\u20133343. https:\/\/doi.org\/10.1093\/brain\/awae203","journal-title":"Brain"},{"issue":"2","key":"3060_CR14","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.neuron.2019.10.010","volume":"105","author":"F Bassil","year":"2020","unstructured":"Bassil F, Brown HJ, Pattabhiraman S, Iwasyk JE, Maghames CM, Meymand ES, Cox TO, Riddle DM, Zhang B, Trojanowski JQ, Lee VM (2020) Amyloid-Beta (Abeta) plaques promote seeding and spreading of Alpha-Synuclein and Tau in a mouse model of lewy body disorders with Abeta pathology. Neuron 105(2):260\u2013275e266. https:\/\/doi.org\/10.1016\/j.neuron.2019.10.010","journal-title":"Neuron"},{"issue":"3","key":"3060_CR15","doi-asserted-by":"publisher","first-page":"861","DOI":"10.3233\/JAD-230207","volume":"94","author":"E Bayram","year":"2023","unstructured":"E, Holden SK, Fullard M, Armstrong MJ, Lewy Body Dementia Association Community Engagement Working G (2023) Race and ethnicity in lewy body dementia: a narrative review. J Alzheimers Dis 94(3):861\u2013878. https:\/\/doi.org\/10.3233\/JAD-230207","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"3060_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.70083","volume":"17","author":"E Bayram","year":"2025","unstructured":"Bayram E, Coughlin DG, Koga S, Ross OA, Litvan I, Dickson DW (2025) Sex differences for regional pathology in people with a high likelihood of Lewy body dementia phenotype based on underlying pathology. Alzheimers Dement Diagn Assess Dis Monit 17(1):e70083. https:\/\/doi.org\/10.1002\/dad2.70083","journal-title":"Alzheimers Dement Diagn Assess Dis Monit"},{"issue":"3","key":"3060_CR17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00401-008-0409-8","volume":"116","author":"TG Beach","year":"2008","unstructured":"Beach TG, White CL, Hamilton RL, Duda JE, Iwatsubo T, Dickson DW, Leverenz JB, Roncaroli F, Buttini M, Hladik CL, Sue LI, Noorigian JV, Adler CH (2008) Evaluation of alpha-synuclein immunohistochemical methods used by invited experts. Acta Neuropathol 116(3):277\u2013288. https:\/\/doi.org\/10.1007\/s00401-008-0409-8","journal-title":"Acta Neuropathol"},{"key":"3060_CR18","doi-asserted-by":"publisher","unstructured":"Beach TG, Adler CH, Lue L, Sue LI, Bachalakuri J, Henry-Watson J, Sasse J, Boyer S, Shirohi S, Brooks R, Eschbacher J, White CL 3rd, Akiyama H, Caviness J, Shill HA, Connor DJ, Sabbagh MN, Walker DG (2009) Arizona Parkinson\u2019s Disease C Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 117 (6):613\u2013634. https:\/\/doi.org\/10.1007\/s00401-009-0538-8","DOI":"10.1007\/s00401-009-0538-8"},{"key":"3060_CR19","doi-asserted-by":"publisher","unstructured":"Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL, Akiyama H, Caviness JN, Shill HA, Sabbagh MN, Walker DG (2010) Arizona Parkinson\u2019s Disease C Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 119 (6):689\u2013702. https:\/\/doi.org\/10.1007\/s00401-010-0664-3","DOI":"10.1007\/s00401-010-0664-3"},{"issue":"12","key":"3060_CR20","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/mds.26431","volume":"30","author":"D Berg","year":"2015","unstructured":"Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G (2015) MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord 30(12):1600\u20131611. https:\/\/doi.org\/10.1002\/mds.26431","journal-title":"Mov Disord"},{"issue":"5","key":"3060_CR21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S1474-4422(13)70054-1","volume":"12","author":"BF Boeve","year":"2013","unstructured":"Boeve BF (2013) Idiopathic REM sleep behaviour disorder in the development of Parkinson\u2019s disease. Lancet Neurol 12(5):469\u2013482. https:\/\/doi.org\/10.1016\/S1474-4422(13)70054-1","journal-title":"Lancet Neurol"},{"issue":"2","key":"3060_CR22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1212\/wnl.51.2.363","volume":"51","author":"BF Boeve","year":"1998","unstructured":"Boeve BF, Silber MH, Ferman TJ, Kokmen E, Smith GE, Ivnik RJ, Parisi JE, Olson EJ, Petersen RC (1998) REM sleep behavior disorder and degenerative dementia: an association likely reflecting lewy body disease. Neurology 51(2):363\u2013370. https:\/\/doi.org\/10.1212\/wnl.51.2.363","journal-title":"Neurology"},{"issue":"4","key":"3060_CR23","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/mds.1120","volume":"16","author":"BF Boeve","year":"2001","unstructured":"Boeve BF, Silber MH, Ferman TJ, Lucas JA, Parisi JE (2001) Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 16(4):622\u2013630. https:\/\/doi.org\/10.1002\/mds.1120","journal-title":"Mov Disord"},{"issue":"1","key":"3060_CR24","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.sleep.2006.08.017","volume":"8","author":"BF Boeve","year":"2007","unstructured":"Boeve BF, Dickson DW, Olson EJ, Shepard JW, Silber MH, Ferman TJ, Ahlskog JE, Benarroch EE (2007) Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant lewy body disease. Sleep Med 8(1):60\u201364. https:\/\/doi.org\/10.1016\/j.sleep.2006.08.017","journal-title":"Sleep Med"},{"issue":"11","key":"3060_CR25","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1002\/mds.26721","volume":"31","author":"BF Boeve","year":"2016","unstructured":"Boeve BF, Dickson DW, Duda JE, Ferman TJ, Galasko DR, Galvin JE, Goldman JG, Growdon JH, Hurtig HI, Kaufer DI, Kantarci K, Leverenz JB, Lippa CF, Lopez OL, McKeith IG, Singleton AB, Taylor A, Tsuang D, Weintraub D, Zabetian CP (2016) Arguing against the proposed definition changes of PD. Mov Disord 31(11):1619\u20131622. https:\/\/doi.org\/10.1002\/mds.26721","journal-title":"Mov Disord"},{"issue":"7","key":"3060_CR26","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S1474-4422(24)00213-8","volume":"23","author":"BF Boeve","year":"2024","unstructured":"Boeve BF, Davis AA, Ju YE, Kantarci K, Singer W, Videnovic A, co-investigators N (2024) Concerns with the new biological research criteria for synucleinopathy. Lancet Neurol 23(7):659\u2013660. https:\/\/doi.org\/10.1016\/S1474-4422(24)00213-8","journal-title":"Lancet Neurol"},{"key":"3060_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105557","volume":"161","author":"P Borghammer","year":"2021","unstructured":"Borghammer P, Horsager J, Andersen K, Van Den Berge N, Raunio A, Murayama S, Parkkinen L, Myllykangas L (2021) Neuropathological evidence of body-first vs. brain-first lewy body disease. Neurobiol Dis 161:105557. https:\/\/doi.org\/10.1016\/j.nbd.2021.105557","journal-title":"Neurobiol Dis"},{"issue":"3","key":"3060_CR28","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3233\/JPD-240002","volume":"14","author":"P Borghammer","year":"2024","unstructured":"Borghammer P, Okkels N, Weintraub D (2024) Parkinson\u2019s disease and dementia with lewy bodies: one and the same. J Parkinsons Dis 14(3):383\u2013397. https:\/\/doi.org\/10.3233\/JPD-240002","journal-title":"J Parkinsons Dis"},{"issue":"2","key":"3060_CR29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic parkinson\u2019s disease. Neurobiol Aging 24(2):197\u2013211 doi:S0197458002000659 [pii]","journal-title":"Neurobiol Aging"},{"issue":"2","key":"3060_CR30","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/mds.29683","volume":"39","author":"F Cardoso","year":"2024","unstructured":"Cardoso F, Goetz CG, Mestre TA, Sampaio C, Adler CH, Berg D, Bloem BR, Burn DJ, Fitts MS, Gasser T, Klein C, de Tijssen MAJ, Lang AE, Lim SY, Litvan I, Meissner WG, Mollenhauer B, Okubadejo N, Okun MS, Postuma RB, Svenningsson P, Tan LCS, Tsunemi T, Wahlstrom-Helgren S, Gershanik OS, Fung VSC, Trenkwalder C (2024) A statement of the MDS on biological Definition, Staging, and classification of parkinson\u2019s disease. Mov Disord 39(2):259\u2013266. https:\/\/doi.org\/10.1002\/mds.29683","journal-title":"Mov Disord"},{"issue":"7","key":"3060_CR31","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S1474-4422(24)00222-9","volume":"23","author":"G Carli","year":"2024","unstructured":"Carli G, Roytman S, Bohnen NI (2024) Concerns with the new biological research criteria for synucleinopathy. Lancet Neurol 23(7):661. https:\/\/doi.org\/10.1016\/S1474-4422(24)00222-9","journal-title":"Lancet Neurol"},{"issue":"9","key":"3060_CR32","doi-asserted-by":"publisher","first-page":"e1267","DOI":"10.1212\/WNL.0000000000010404","volume":"95","author":"LM Chahine","year":"2020","unstructured":"Chahine LM, Beach TG, Brumm MC, Adler CH, Coffey CS, Mosovsky S, Caspell-Garcia C, Serrano GE, Munoz DG, White CL 3rd, Crary JF, Jennings D, Taylor P, Foroud T, Arnedo V, Kopil CM, Riley L, Dave KD, Mollenhauer B, Systemic S, Sampling S (2020) In vivo distribution of alpha-synuclein in multiple tissues and biofluids in Parkinson disease. Neurology 95(9):e1267\u2013e1284. https:\/\/doi.org\/10.1212\/WNL.0000000000010404","journal-title":"Neurology"},{"issue":"9440","key":"3060_CR33","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"MC Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, Levecque C, Larvor L, Andrieux J, Hulihan M, Waucquier N, Defebvre L, Amouyel P, Farrer M, Destee A (2004) Alpha-synuclein locus duplication as a cause of Familial parkinson\u2019s disease. Lancet 364(9440):1167\u20131169. https:\/\/doi.org\/10.1016\/S0140-6736(04)17103-1","journal-title":"Lancet"},{"issue":"3","key":"3060_CR34","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41588-021-00785-3","volume":"53","author":"R Chia","year":"2021","unstructured":"Chia R, Sabir MS, Bandres-Ciga S, Saez-Atienzar S, Reynolds RH, Gustavsson E, Walton RL, Ahmed S, Viollet C, Ding J, Makarious MB, Diez-Fairen M, Portley MK, Shah Z, Abramzon Y, Hernandez DG, Blauwendraat C, Stone DJ, Eicher J, Parkkinen L, Ansorge O, Clark L, Honig LS, Marder K, Lemstra A, St George-Hyslop P, Londos E, Morgan K, Lashley T, Warner TT, Jaunmuktane Z, Galasko D, Santana I, Tienari PJ, Myllykangas L, Oinas M, Cairns NJ, Morris JC, Halliday GM, Van Deerlin VM, Trojanowski JQ, Grassano M, Calvo A, Mora G, Canosa A, Floris G, Bohannan RC, Brett F, Gan-Or Z, Geiger JT, Moore A, May P, Kruger R, Goldstein DS, Lopez G, Tayebi N, Sidransky E, American Genome C, Norcliffe-Kaufmann L, Palma JA, Kaufmann H, Shakkottai VG, Perkins M, Newell KL, Gasser T, Schulte C, Landi F, Salvi E, Cusi D, Masliah E, Kim RC, Caraway CA, Monuki ES, Brunetti M, Dawson TM, Rosenthal LS, Albert MS, Pletnikova O, Troncoso JC, Flanagan ME, Mao Q, Bigio EH, Rodriguez-Rodriguez E, Infante J, Lage C, Gonzalez-Aramburu I, Sanchez-Juan P, Ghetti B, Keith J, Black SE, Masellis M, Rogaeva E, Duyckaerts C, Brice A, Lesage S, Xiromerisiou G, Barrett MJ, Tilley BS, Gentleman S, Logroscino G, Serrano GE, Beach TG, McKeith IG, Thomas AJ, Attems J, Morris CM, Palmer L, Love S, Troakes C, Al-Sarraj S, Hodges AK, Aarsland D, Klein G, Kaiser SM, Woltjer R, Pastor P, Bekris LM, Leverenz JB, Besser LM, Kuzma A, Renton AE, Goate A, Bennett DA, Scherzer CR, Morris HR, Ferrari R, Albani D, Pickering-Brown S, Faber K, Kukull WA, Morenas-Rodriguez E, Lleo A, Fortea J, Alcolea D, Clarimon J, Nalls MA, Ferrucci L, Resnick SM, Tanaka T, Foroud TM, Graff-Radford NR, Wszolek ZK, Ferman T, Boeve BF, Hardy JA, Topol EJ, Torkamani A, Singleton AB, Ryten M, Dickson DW, Chio A, Ross OA, Gibbs JR, Dalgard CL, Traynor BJ, Scholz SW (2021) Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture. Nat Genet 53(3):294\u2013303. https:\/\/doi.org\/10.1038\/s41588-021-00785-3","journal-title":"Nat Genet"},{"issue":"7","key":"3060_CR35","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/jamaneurol.2015.0606","volume":"72","author":"EJ Chung","year":"2015","unstructured":"Chung EJ, Babulal GM, Monsell SE, Cairns NJ, Roe CM, Morris JC (2015) Clinical features of Alzheimer disease with and without Lewy bodies. JAMA Neurol 72(7):789\u2013796. https:\/\/doi.org\/10.1001\/jamaneurol.2015.0606","journal-title":"JAMA Neurol"},{"issue":"5","key":"3060_CR36","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1001\/archneurol.2009.54","volume":"66","author":"LN Clark","year":"2009","unstructured":"Clark LN, Kartsaklis LA, Wolf Gilbert R, Dorado B, Ross BM, Kisselev S, Verbitsky M, Mejia-Santana H, Cote LJ, Andrews H, Vonsattel JP, Fahn S, Mayeux R, Honig LS, Marder K (2009) Association of glucocerebrosidase mutations with dementia with Lewy bodies. Arch Neurol 66(5):578\u2013583. https:\/\/doi.org\/10.1001\/archneurol.2009.54","journal-title":"Arch Neurol"},{"issue":"8","key":"3060_CR37","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S1474-4422(12)70142-4","volume":"11","author":"CM Clark","year":"2012","unstructured":"Clark CM, Pontecorvo MJ, Beach TG, Bedell BJ, Coleman RE, Doraiswamy PM, Fleisher AS, Reiman EM, Sabbagh MN, Sadowsky CH, Schneider JA, Arora A, Carpenter AP, Flitter ML, Joshi AD, Krautkramer MJ, Lu M, Mintun MA, Skovronsky DM, Group A-AS (2012) Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-beta plaques: a prospective cohort study. Lancet Neurol 11(8):669\u2013678. https:\/\/doi.org\/10.1016\/S1474-4422(12)70142-4","journal-title":"Lancet Neurol"},{"key":"3060_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2024.103714","volume":"45","author":"JS Cohen","year":"2025","unstructured":"Cohen JS, Phillips J, Das SR, Olm CA, Radhakrishnan H, Rhodes E, Cousins KAQ, Xie SX, Nasrallah IM, Yushkevich PA, Wolk DA, Lee EB, Weintraub D, Irwin DJ, McMillan CT (2025) Posterior hippocampal sparing in lewy body disorders with Alzheimer\u2019s copathology: an in vivo MRI study. Neuroimage Clin 45:103714. https:\/\/doi.org\/10.1016\/j.nicl.2024.103714","journal-title":"Neuroimage Clin"},{"issue":"Pt 9","key":"3060_CR39","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1093\/brain\/aws211","volume":"135","author":"SJ Colloby","year":"2012","unstructured":"Colloby SJ, McParland S, O\u2019Brien JT, Attems J (2012) Neuropathological correlates of dopaminergic imaging in alzheimer\u2019s disease and lewy body dementias. Brain 135(Pt 9):2798\u20132808. https:\/\/doi.org\/10.1093\/brain\/aws211","journal-title":"Brain"},{"issue":"5","key":"3060_CR40","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1093\/brain\/awae372","volume":"148","author":"SJ Colloby","year":"2025","unstructured":"Colloby SJ, McAleese KE, Walker L, Erskine D, Toledo JB, Donaghy PC, McKeith IG, Thomas AJ, Attems J, Taylor JP (2025) Patterns of tau, amyloid and synuclein pathology in ageing, Alzheimer\u2019s disease and synucleinopathies. Brain 148(5):1562\u20131576. https:\/\/doi.org\/10.1093\/brain\/awae372","journal-title":"Brain"},{"issue":"7","key":"3060_CR41","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1136\/jnnp.74.7.852","volume":"74","author":"C Colosimo","year":"2003","unstructured":"Colosimo C, Hughes AJ, Kilford L, Lees AJ (2003) Lewy body cortical involvement May not always predict dementia in parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 74(7):852\u2013856. https:\/\/doi.org\/10.1136\/jnnp.74.7.852","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 5","key":"3060_CR42","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/brain\/awr031","volume":"134","author":"Y Compta","year":"2011","unstructured":"Compta Y, Parkkinen L, O\u2019Sullivan SS, Vandrovcova J, Holton JL, Collins C, Lashley T, Kallis C, Williams DR, de Silva R, Lees AJ, Revesz T (2011) Lewy- and Alzheimer-type pathologies in Parkinson\u2019s disease dementia: which is more important? Brain 134(Pt 5):1493\u20131505. https:\/\/doi.org\/10.1093\/brain\/awr031","journal-title":"Brain"},{"issue":"4","key":"3060_CR43","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1007\/s13311-023-01379-z","volume":"20","author":"DG Coughlin","year":"2023","unstructured":"Coughlin DG, Irwin DJ (2023) Fluid and biopsy based biomarkers in Parkinson\u2019s disease. Neurotherapeutics 20(4):932\u2013954. https:\/\/doi.org\/10.1007\/s13311-023-01379-z","journal-title":"Neurotherapeutics"},{"issue":"2","key":"3060_CR44","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/ana.25392","volume":"85","author":"D Coughlin","year":"2019","unstructured":"Coughlin D, Xie SX, Liang M, Williams A, Peterson C, Weintraub D, McMillan CT, Wolk DA, Akhtar RS, Hurtig HI, Coslett HB, Hamilton RH, Siderowf AD, Duda JE, Rascovsky K, Lee EB, Lee VMY, Grossman M, Trojanowski JQ, Irwin DJ (2019) Cognitive and pathological influences of Tau pathology in lewy body disorders. Ann Neurol 85(2):259\u2013271. https:\/\/doi.org\/10.1002\/ana.25392","journal-title":"Ann Neurol"},{"issue":"1","key":"3060_CR45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/mds.27867","volume":"35","author":"DG Coughlin","year":"2020","unstructured":"Coughlin DG, Hurtig HI, Irwin DJ (2020a) Pathological influences on clinical heterogeneity in lewy body diseases. Mov Disord 35(1):5\u201319. https:\/\/doi.org\/10.1002\/mds.27867","journal-title":"Mov Disord"},{"issue":"7","key":"3060_CR46","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/nan.12659","volume":"46","author":"DG Coughlin","year":"2020","unstructured":"Coughlin DG, Ittyerah R, Peterson C, Phillips JS, Miller S, Rascovsky K, Weintraub D, Siderowf AD, Duda JE, Hurtig HI, Wolk DA, McMillan CT, Yushkevich PA, Grossman M, Lee EB, Trojanowski JQ, Irwin DJ (2020b) Hippocampal subfield pathologic burden in lewy body diseases vs. Alzheimer\u2019s disease. Neuropathol Appl Neurobiol 46(7):707\u2013721. https:\/\/doi.org\/10.1111\/nan.12659","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3060_CR47","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.neurobiolaging.2020.08.003","volume":"96","author":"DG Coughlin","year":"2020","unstructured":"Coughlin DG, Phillips JS, Roll E, Peterson C, Lobrovich R, Rascovsky K, Ungrady M, Wolk DA, Das S, Weintraub D, Lee EB, Trojanowski JQ, Shaw LM, Vaishnavi S, Siderowf A, Nasrallah IM, Irwin DJ, McMillan CT, Neuroimaging IAsD (2020c) Multimodal in vivo and postmortem assessments of tau in lewy body disorders. Neurobiol Aging 96:137\u2013147. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.08.003","journal-title":"Neurobiol Aging"},{"issue":"20","key":"3060_CR48","doi-asserted-by":"publisher","first-page":"e2303","DOI":"10.1212\/WNL.0000000000201202","volume":"99","author":"KAQ Cousins","year":"2022","unstructured":"Cousins KAQ, Arezoumandan S, Shellikeri S, Ohm D, Shaw LM, Grossman M, Wolk D, McMillan CT, Chen-Plotkin A, Lee E, Trojanowski JQ, Zetterberg H, Blennow K, Irwin DJ (2022) CSF biomarkers of alzheimer disease in patients with concomitant alpha-Synuclein pathology. Neurology 99(20):e2303\u2013e2312. https:\/\/doi.org\/10.1212\/WNL.0000000000201202","journal-title":"Neurology"},{"issue":"5","key":"3060_CR49","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/acn3.51768","volume":"10","author":"KAQ Cousins","year":"2023","unstructured":"Cousins KAQ, Irwin DJ, Chen-Plotkin A, Shaw LM, Arezoumandan S, Lee EB, Wolk DA, Weintraub D, Spindler M, Deik A, Grossman M, Tropea TF (2023) Plasma GFAP associates with secondary Alzheimer\u2019s pathology in lewy body disease. Ann Clin Transl Neurol 10(5):802\u2013813. https:\/\/doi.org\/10.1002\/acn3.51768","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"3060_CR50","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000208033","volume":"102","author":"KAQ Cousins","year":"2024","unstructured":"Cousins K, Irwin DJ, Tropea TF, Rhodes E, Phillips J, Chen-Plotkin AS, Brumm MC, Coffey CS, Kang JH, Simuni T, Foroud TM, Toga AW, Tanner CM, Kieburtz KD, Mollenhauer B, Galasko D, Hutten S, Weintraub D, Siderowf AD, Marek K, Poston KL, Shaw LM (2024) Parkinson\u2019s progression markers I evaluation of ATN(PD) framework and biofluid markers to predict cognitive decline in early Parkinson disease. Neurology 102(4):e208033. https:\/\/doi.org\/10.1212\/WNL.0000000000208033","journal-title":"Neurology"},{"issue":"1","key":"3060_CR51","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1177\/089198878800100106","volume":"1","author":"JL Cummings","year":"1988","unstructured":"Cummings JL (1988) Intellectual impairment in Parkinson\u2019s disease: clinical, pathologic, and biochemical correlates. J Geriatr Psychiatry Neurol 1(1):24\u201336. https:\/\/doi.org\/10.1177\/089198878800100106","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"5","key":"3060_CR52","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","volume":"61","author":"K Del Tredici","year":"2002","unstructured":"Del Tredici K, Rub U, De Vos RA, Bohl JR, Braak H (2002) Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61(5):413\u2013426. https:\/\/doi.org\/10.1093\/jnen\/61.5.413","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"3060_CR53","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1093\/brain\/awaf003","volume":"148","author":"A Delva","year":"2025","unstructured":"Delva A, Pelletier A, Somerville E, Montplaisir J, Gagnon JF, Kollmorgen G, Kam-Thong T, Kustermann T, Machado V, Gan-Or Z, Postuma RB (2025) Plasma pTau181 and amyloid markers predict conversion to dementia in idiopathic REM sleep behaviour disorder. Brain 148(6):2049\u20132059. https:\/\/doi.org\/10.1093\/brain\/awaf003","journal-title":"Brain"},{"issue":"4","key":"3060_CR54","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1002\/alz.13653","volume":"20","author":"P Diaz-Galvan","year":"2024","unstructured":"Diaz-Galvan P, Przybelski SA, Algeciras-Schimnich A, Figdore DJ, Lesnick TG, Schwarz CG, Senjem ML, Gunter JL, Jack CR Jr., Min PH, Jain MK, Miyagawa T, Forsberg LK, Fields JA, Savica R, Graff-Radford J, Ramanan VK, Jones DT, Botha H, St Louis EK, Knopman DS, Graff-Radford NR, Ferman TJ, Petersen RC, Lowe VJ, Boeve BF, Kantarci K (2024) Plasma biomarkers of Alzheimer\u2019s disease in the continuum of dementia with Lewy bodies. Alzheimers Dement 20(4):2485\u20132496. https:\/\/doi.org\/10.1002\/alz.13653","journal-title":"Alzheimers Dement"},{"issue":"4","key":"3060_CR55","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00401-008-0345-7","volume":"115","author":"DW Dickson","year":"2008","unstructured":"Dickson DW, Fujishiro H, DelleDonne A, Menke J, Ahmed Z, Klos KJ, Josephs KA, Frigerio R, Burnett M, Parisi JE, Ahlskog JE (2008) Evidence that incidental lewy body disease is pre-symptomatic Parkinson\u2019s disease. Acta Neuropathol 115(4):437\u2013444. https:\/\/doi.org\/10.1007\/s00401-008-0345-7","journal-title":"Acta Neuropathol"},{"issue":"12","key":"3060_CR56","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","volume":"8","author":"DW Dickson","year":"2009","unstructured":"Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, Hardy J, Leverenz JB, Del Tredici K, Wszolek ZK, Litvan I (2009) Neuropathological assessment of Parkinson\u2019s disease: refining the diagnostic criteria. Lancet Neurol 8(12):1150\u20131157. https:\/\/doi.org\/10.1016\/S1474-4422(09)70238-8","journal-title":"Lancet Neurol"},{"issue":"7","key":"3060_CR57","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1002\/alz.13105","volume":"19","author":"Donaghy PC, Carrarini C, Ferreira D, Habich A, Aarsland D, Babiloni C, Bayram E, Kane JP, Lewis SJ, Pilotto A, Thomas AJ, Bonanni L, Alzheimer\u2019s Association International Society to Advance Alzheimer\u2019s R, Treatment Lewy Body Dementias Prodromal Working G","year":"2023","unstructured":"Donaghy PC, Carrarini C, Ferreira D, Habich A, Aarsland D, Babiloni C, Bayram E, Kane JP, Lewis SJ, Pilotto A, Thomas AJ, Bonanni L, Alzheimer\u2019s Association International Society to Advance Alzheimer\u2019s R, Treatment Lewy Body Dementias Prodromal Working G (2023) Research diagnostic criteria for mild cognitive impairment with Lewy bodies: a systematic review and meta-analysis. Alzheimers Dement 19(7):3186\u20133202. https:\/\/doi.org\/10.1002\/alz.13105","journal-title":"Alzheimers Dement"},{"issue":"12","key":"3060_CR58","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1001\/jamaneurol.2024.3770","volume":"81","author":"B Dubois","year":"2024","unstructured":"Dubois B, Villain N, Schneider L, Fox N, Campbell N, Galasko D, Kivipelto M, Jessen F, Hanseeuw B, Boada M, Barkhof F, Nordberg A, Froelich L, Waldemar G, Frederiksen KS, Padovani A, Planche V, Rowe C, Bejanin A, Ibanez A, Cappa S, Caramelli P, Nitrini R, Allegri R, Slachevsky A, de Souza LC, Bozoki A, Widera E, Blennow K, Ritchie C, Agronin M, Lopera F, Delano-Wood L, Bombois S, Levy R, Thambisetty M, Georges J, Jones DT, Lavretsky H, Schott J, Gatchel J, Swantek S, Newhouse P, Feldman HH, Frisoni GB (2024) Alzheimer disease as a clinical-biological construct-an international working group recommendation. JAMA Neurol 81(12):1304\u20131311. https:\/\/doi.org\/10.1001\/jamaneurol.2024.3770","journal-title":"JAMA Neurol"},{"issue":"2","key":"3060_CR59","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/ana.10279","volume":"52","author":"JE Duda","year":"2002","unstructured":"Duda JE, Giasson BI, Mabon ME, Lee VM, Trojanowski JQ (2002a) Novel antibodies to synuclein show abundant striatal pathology in lewy body diseases. Ann Neurol 52(2):205\u2013210. https:\/\/doi.org\/10.1002\/ana.10279","journal-title":"Ann Neurol"},{"issue":"1","key":"3060_CR60","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00401-002-0563-3","volume":"104","author":"JE Duda","year":"2002","unstructured":"Duda JE, Giasson BI, Mabon ME, Miller DC, Golbe LI, Lee VM, Trojanowski JQ (2002b) Concurrence of alpha-synuclein and Tau brain pathology in the contursi kindred. Acta Neuropathol 104(1):7\u201311. https:\/\/doi.org\/10.1007\/s00401-002-0563-3","journal-title":"Acta Neuropathol"},{"issue":"2","key":"3060_CR61","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1365-2990.2011.01203.x","volume":"38","author":"BN Dugger","year":"2012","unstructured":"Dugger BN, Murray ME, Boeve BF, Parisi JE, Benarroch EE, Ferman TJ, Dickson DW (2012) Neuropathological analysis of brainstem cholinergic and catecholaminergic nuclei in relation to rapid eye movement (REM) sleep behaviour disorder. Neuropathol Appl Neurobiol 38(2):142\u2013152. https:\/\/doi.org\/10.1111\/j.1365-2990.2011.01203.x","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"5","key":"3060_CR62","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1093\/brain\/awae352","volume":"148","author":"MT Duong","year":"2025","unstructured":"Duong MT, Das SR, Khandelwal P, Lyu X, Xie L, McGrew E, Dehghani N, McMillan CT, Lee EB, Shaw LM, Yushkevich PA, Wolk DA, Nasrallah IM (2025) Hypometabolic mismatch with atrophy and Tau pathology in mixed Alzheimer\u2019s and lewy body disease. Brain 148(5):1577\u20131587. https:\/\/doi.org\/10.1093\/brain\/awae352","journal-title":"Brain"},{"issue":"12","key":"3060_CR63","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord 22(12):1689\u20131707. https:\/\/doi.org\/10.1002\/mds.21507","journal-title":"Mov Disord"},{"issue":"7","key":"3060_CR64","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/S1474-4422(24)00214-X","volume":"23","author":"F Escamilla-Sevilla","year":"2024","unstructured":"Escamilla-Sevilla F, Freire-Alvarez E, Martinez Castrillo JC, Sanchez Ferro A, Santos-Garcia D (2024) Concerns with the new biological research criteria for synucleinopathy. Lancet Neurol 23(7):662. https:\/\/doi.org\/10.1016\/S1474-4422(24)00214-X","journal-title":"Lancet Neurol"},{"issue":"10","key":"3060_CR65","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/acn3.338","volume":"3","author":"G Fairfoul","year":"2016","unstructured":"Fairfoul G, McGuire LI, Pal S, Ironside JW, Neumann J, Christie S, Joachim C, Esiri M, Evetts SG, Rolinski M, Baig F, Ruffmann C, Wade-Martins R, Hu MT, Parkkinen L, Green AJ (2016) Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies. Ann Clin Transl Neurol 3(10):812\u2013818. https:\/\/doi.org\/10.1002\/acn3.338","journal-title":"Ann Clin Transl Neurol"},{"issue":"7","key":"3060_CR66","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1093\/brain\/awz111","volume":"142","author":"SM Fereshtehnejad","year":"2019","unstructured":"Fereshtehnejad SM, Yao C, Pelletier A, Montplaisir JY, Gagnon JF, Postuma RB (2019) Evolution of prodromal Parkinson\u2019s disease and dementia with Lewy bodies: a prospective study. Brain 142(7):2051\u20132067. https:\/\/doi.org\/10.1093\/brain\/awz111","journal-title":"Brain"},{"issue":"3","key":"3060_CR67","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jalz.2017.09.014","volume":"14","author":"TJ Ferman","year":"2018","unstructured":"Ferman TJ, Aoki N, Crook JE, Murray ME, Graff-Radford NR, van Gerpen JA, Uitti RJ, Wszolek ZK, Graff-Radford J, Pedraza O, Kantarci K, Boeve BF, Dickson DW (2018) The limbic and neocortical contribution of alpha-synuclein, tau, and amyloid beta to disease duration in dementia with lewy bodies. Alzheimers Dement 14(3):330\u2013339. https:\/\/doi.org\/10.1016\/j.jalz.2017.09.014","journal-title":"Alzheimers Dement"},{"issue":"2","key":"3060_CR68","doi-asserted-by":"publisher","first-page":"e155","DOI":"10.1212\/WNL.0000000000009763","volume":"95","author":"TJ Ferman","year":"2020","unstructured":"Ferman TJ, Aoki N, Boeve BF, Aakre JA, Kantarci K, Graff-Radford J, Parisi JE, Van Gerpen JA, Graff-Radford NR, Uitti RJ, Pedraza O, Murray ME, Wszolek ZK, Reichard RR, Fields JA, Ross OA, Knopman DS, Petersen RC, Dickson DW (2020) Subtypes of dementia with lewy bodies are associated with alpha-synuclein and Tau distribution. Neurology 95(2):e155\u2013e165. https:\/\/doi.org\/10.1212\/WNL.0000000000009763","journal-title":"Neurology"},{"issue":"24","key":"3060_CR69","doi-asserted-by":"publisher","first-page":"e3257","DOI":"10.1212\/WNL.0000000000010943","volume":"95","author":"D Ferreira","year":"2020","unstructured":"Ferreira D, Przybelski SA, Lesnick TG, Lemstra AW, Londos E, Blanc F, Nedelska Z, Schwarz CG, Graff-Radford J, Senjem ML, Fields JA, Knopman DS, Savica R, Ferman TJ, Graff-Radford NR, Lowe VJ, Jack CR Jr., Petersen RC, Mollenhauer B, Garcia-Ptacek S, Abdelnour C, Hort J, Bonanni L, Oppedal K, Kramberger MG, Boeve BF, Aarsland D, Westman E, Kantarci K (2020) beta-Amyloid and Tau biomarkers and clinical phenotype in dementia with lewy bodies. Neurology 95(24):e3257\u2013e3268. https:\/\/doi.org\/10.1212\/WNL.0000000000010943","journal-title":"Neurology"},{"key":"3060_CR70","doi-asserted-by":"publisher","unstructured":"Fleisher AS, Pontecorvo MJ, D SDM, Lu M, Arora AK, Truocchio SP, Aldea P, Flitter M, Locascio T, Devine M, Siderowf A, Beach TG, Montine TJ, Serrano GE, Curtis C, Perrin A, Salloway S, Daniel M, Wellman C, Joshi AD, Irwin DJ, Lowe VJ, Seeley WW, Ikonomovic MD, Masdeu JC, Kennedy I, Harris T, Navitsky M, Southekal S, Mintun MA (2020) Investigators AS positron emission tomography imaging with [18F]flortaucipir and postmortem assessment of alzheimer disease neuropathologic changes. JAMA Neurol 77:829\u2013839. https:\/\/doi.org\/10.1001\/jamaneurol.2020.0528","DOI":"10.1001\/jamaneurol.2020.0528"},{"issue":"5","key":"3060_CR71","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.neurobiolaging.2009.05.019","volume":"32","author":"R Frigerio","year":"2011","unstructured":"Frigerio R, Fujishiro H, Ahn TB, Josephs KA, Maraganore DM, DelleDonne A, Parisi JE, Klos KJ, Boeve BF, Dickson DW, Ahlskog JE (2011) Incidental lewy body disease: do some cases represent a preclinical stage of dementia with lewy bodies? Neurobiol Aging 32(5):857\u2013863. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2009.05.019","journal-title":"Neurobiol Aging"},{"issue":"5","key":"3060_CR72","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209699","volume":"103","author":"J Gallagher","year":"2024","unstructured":"Gallagher J, Gochanour C, Caspell-Garcia C, Dobkin RD, Aarsland D, Alcalay RN, Barrett MJ, Chahine L, Chen-Plotkin AS, Coffey CS, Dahodwala N, Eberling JL, Espay AJ, Leverenz JB, Litvan I, Mamikonyan E, Morley J, Richard IH, Rosenthal L, Siderowf AD, Simuni T, York MK, Willis AW, Xie SX, Weintraub D, Parkinson\u2019s Progression Markers I (2024) Long-term dementia risk in Parkinson disease. Neurology 103(5):e209699. https:\/\/doi.org\/10.1212\/WNL.0000000000209699","journal-title":"Neurology"},{"issue":"6","key":"3060_CR73","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.parkreldis.2010.03.007","volume":"16","author":"JE Galvin","year":"2010","unstructured":"Galvin JE, Duda JE, Kaufer DI, Lippa CF, Taylor A, Zarit SH (2010) Lewy body dementia: the caregiver experience of clinical care. Parkinsonism Relat Disord 16(6):388\u2013392. https:\/\/doi.org\/10.1016\/j.parkreldis.2010.03.007","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"3060_CR74","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/mds.29284","volume":"38","author":"A Garrido","year":"2023","unstructured":"Garrido A, Fairfoul G, Tolosa E, Marti MJ, Ezquerra M, Green AJE (2023) Brain and cerebrospinal fluid alpha-Synuclein Real-Time Quaking-Induced conversion identifies lewy body pathology in LRRK2-PD. Mov Disord 38(2):333\u2013338. https:\/\/doi.org\/10.1002\/mds.29284","journal-title":"Mov Disord"},{"issue":"6","key":"3060_CR75","doi-asserted-by":"publisher","first-page":"fcae442","DOI":"10.1093\/braincomms\/fcae442","volume":"6","author":"K Gawor","year":"2024","unstructured":"Gawor K, Tome SO, Vandenberghe R, Van Damme P, Vandenbulcke M, Otto M, von Arnim CAF, Ghebremedhin E, Ronisz A, Ospitalieri S, Blaschko M, Thal DR (2024) Amygdala-predominant alpha-synuclein pathology is associated with exacerbated hippocampal neuron loss in alzheimer\u2019s disease. Brain Commun 6(6):fcae442. https:\/\/doi.org\/10.1093\/braincomms\/fcae442","journal-title":"Brain Commun"},{"issue":"7","key":"3060_CR76","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2217\/bmm-2021-0646","volume":"16","author":"CH Gibbons","year":"2022","unstructured":"Gibbons CH, Freeman R, Bellaire B, Adler CH, Moore D, Levine T (2022) Synuclein-One study: skin biopsy detection of phosphorylated alpha-synuclein for diagnosis of synucleinopathies. Biomark Med 16(7):499\u2013509. https:\/\/doi.org\/10.2217\/bmm-2021-0646","journal-title":"Biomark Med"},{"issue":"15","key":"3060_CR77","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1001\/jama.2024.0792","volume":"331","author":"CH Gibbons","year":"2024","unstructured":"Gibbons CH, Levine T, Adler C, Bellaire B, Wang N, Stohl J, Agarwal P, Aldridge GM, Barboi A, Evidente VGH, Galasko D, Geschwind MD, Gonzalez-Duarte A, Gil R, Gudesblatt M, Isaacson SH, Kaufmann H, Khemani P, Kumar R, Lamotte G, Liu AJ, McFarland NR, Miglis M, Reynolds A, Sahagian GA, Saint-Hillaire MH, Schwartzbard JB, Singer W, Soileau MJ, Vernino S, Yerstein O, Freeman R (2024) Skin biopsy detection of phosphorylated alpha-Synuclein in patients with synucleinopathies. JAMA 331(15):1298\u20131306. https:\/\/doi.org\/10.1001\/jama.2024.0792","journal-title":"JAMA"},{"issue":"1","key":"3060_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00703-5","volume":"12","author":"JG Goldman","year":"2020","unstructured":"Goldman JG, Forsberg LK, Boeve BF, Armstrong MJ, Irwin DJ, Ferman TJ, Galasko D, Galvin JE, Kaufer D, Leverenz J, Lippa CF, Marder K, Abler V, Biglan K, Irizarry M, Keller B, Munsie L, Nakagawa M, Taylor A, Graham T (2020) Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials. Alzheimers Res Ther 12(1):137. https:\/\/doi.org\/10.1186\/s13195-020-00703-5","journal-title":"Alzheimers Res Ther"},{"issue":"7","key":"3060_CR79","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S1474-4422(24)00225-4","volume":"23","author":"JG Goldman","year":"2024","unstructured":"Goldman JG, Boeve BF, Galasko D, Galvin JE, Leverenz JB, Taylor JP (2024) Concerns with the new biological research criteria for synucleinopathy. Lancet Neurol 23(7):660\u2013661. https:\/\/doi.org\/10.1016\/S1474-4422(24)00225-4","journal-title":"Lancet Neurol"},{"issue":"7","key":"3060_CR80","doi-asserted-by":"publisher","first-page":"e70470","DOI":"10.1002\/alz.70470","volume":"21","author":"JG Goldman","year":"2025","unstructured":"Goldman JG, Boeve BF, Galasko D, Taylor JP, Galvin JE, Leverenz JB, Blanc F, Halliday G, Kantarci K, Lemstra AW, Leroi I, Lewis SJG, Litvan I, Medsger H, O\u2019Brien J, Scholz SW, Aarsland D, Ikeda M, McKeith I, Taylor A (2025) Implications and opportunities regarding biological frameworks in overt and prodromal dementia with lewy bodies. Alzheimer\u2019s Dement 21(7):e70470. https:\/\/doi.org\/10.1002\/alz.70470","journal-title":"Alzheimer\u2019s Dement"},{"issue":"11","key":"3060_CR81","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1001\/jamaneurol.2016.3338","volume":"73","author":"SN Gomperts","year":"2016","unstructured":"Gomperts SN, Locascio JJ, Makaretz SJ, Schultz A, Caso C, Vasdev N, Sperling R, Growdon JH, Dickerson BC, Johnson K (2016) Tau positron emission tomographic imaging in the Lewy body diseases. JAMA Neurol 73(11):1334\u20131341. https:\/\/doi.org\/10.1001\/jamaneurol.2016.3338","journal-title":"JAMA Neurol"},{"issue":"9","key":"3060_CR82","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1212\/WNL.0000000000000734","volume":"83","author":"J Graff-Radford","year":"2014","unstructured":"Graff-Radford J, Murray ME, Lowe VJ, Boeve BF, Ferman TJ, Przybelski SA, Lesnick TG, Senjem ML, Gunter JL, Smith GE, Knopman DS, Jack CR Jr., Dickson DW, Petersen RC, Kantarci K (2014) Dementia with lewy bodies: basis of cingulate island sign. Neurology 83(9):801\u2013809. https:\/\/doi.org\/10.1212\/WNL.0000000000000734","journal-title":"Neurology"},{"issue":"1","key":"3060_CR83","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40478-018-0508-2","volume":"6","author":"BR Groveman","year":"2018","unstructured":"Groveman BR, Orru CD, Hughson AG, Raymond LD, Zanusso G, Ghetti B, Campbell KJ, Safar J, Galasko D, Caughey B (2018) Rapid and ultra-sensitive quantitation of disease-associated alpha-synuclein seeds in brain and cerebrospinal fluid by AlphaSyn RT-QuIC. Acta Neuropathol Commun 6(1):7. https:\/\/doi.org\/10.1186\/s40478-018-0508-2","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"3060_CR84","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S1474-4422(17)30400-3","volume":"17","author":"R Guerreiro","year":"2018","unstructured":"Guerreiro R, Ross OA, Kun-Rodrigues C, Hernandez DG, Orme T, Eicher JD, Shepherd CE, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Ansorge O, Clarimon J, Lleo A, Morenas-Rodriguez E, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Diez-Fairen M, Aguilar M, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday GM, Hardy J, Trojanowski JQ, Dickson DW, Singleton A, Stone DJ, Bras J (2018) Investigating the genetic architecture of dementia with lewy bodies: a two-stage genome-wide association study. Lancet Neurol 17(1):64\u201374. https:\/\/doi.org\/10.1016\/S1474-4422(17)30400-3","journal-title":"Lancet Neurol"},{"issue":"2","key":"3060_CR85","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nm.3457","volume":"20","author":"JL Guo","year":"2014","unstructured":"Guo JL, Lee VM (2014) Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat Med 20(2):130\u2013138. https:\/\/doi.org\/10.1038\/nm.3457","journal-title":"Nat Med"},{"issue":"1","key":"3060_CR86","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cell.2013.05.057","volume":"154","author":"JL Guo","year":"2013","unstructured":"Guo JL, Covell DJ, Daniels JP, Iba M, Stieber A, Zhang B, Riddle DM, Kwong LK, Xu Y, Trojanowski JQ, Lee VM (2013) Distinct alpha-synuclein strains differentially promote Tau inclusions in neurons. Cell 154(1):103\u2013117. https:\/\/doi.org\/10.1016\/j.cell.2013.05.057","journal-title":"Cell"},{"issue":"2","key":"3060_CR87","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00401-011-0852-9","volume":"122","author":"GM Halliday","year":"2011","unstructured":"Halliday GM, Holton JL, Revesz T, Dickson DW (2011) Neuropathology underlying clinical variability in patients with synucleinopathies. Acta Neuropathol 122(2):187\u2013204. https:\/\/doi.org\/10.1007\/s00401-011-0852-9","journal-title":"Acta Neuropathol"},{"issue":"3","key":"3060_CR88","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","volume":"10","author":"RL Hamilton","year":"2000","unstructured":"Hamilton RL (2000) Lewy bodies in alzheimer\u2019s disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol 10(3):378\u2013384. https:\/\/doi.org\/10.1111\/j.1750-3639.2000.tb00269.x","journal-title":"Brain Pathol"},{"issue":"1","key":"3060_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/wnl.40.1.1","volume":"40","author":"L Hansen","year":"1990","unstructured":"Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thal L, Pay MM, Hofstetter R, Klauber M et al (1990) The lewy body variant of alzheimer\u2019s disease: a clinical and pathologic entity. Neurology 40(1):1\u20138. https:\/\/doi.org\/10.1212\/wnl.40.1.1","journal-title":"Neurology"},{"issue":"1","key":"3060_CR90","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/nan.12648","volume":"47","author":"D Hansen","year":"2021","unstructured":"Hansen D, Ling H, Lashley T, Foley JA, Strand C, Eid TM, Holton JL, Warner TT (2021) Novel clinicopathological characteristics differentiate dementia with lewy bodies from Parkinson\u2019s disease dementia. Neuropathol Appl Neurobiol 47(1):143\u2013156. https:\/\/doi.org\/10.1111\/nan.12648","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"3060_CR91","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s004010100390","volume":"102","author":"AJ Harding","year":"2001","unstructured":"Harding AJ, Halliday GM (2001) Cortical lewy body pathology in the diagnosis of dementia. Acta Neuropathol 102(4):355\u2013363. https:\/\/doi.org\/10.1007\/s004010100390","journal-title":"Acta Neuropathol"},{"issue":"4","key":"3060_CR92","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1093\/brain\/awac002","volume":"145","author":"C Hatton","year":"2022","unstructured":"Hatton C, Ghanem SS, Koss DJ, Abdi IY, Gibbons E, Guerreiro R, Bras J, International DLBGC, Walker L, Gelpi E, Heywood W, Outeiro TF, Attems J, McFarland R, Forsyth R, El-Agnaf OM, Erskine D (2022) Prion-like alpha-synuclein pathology in the brain of infants with Krabbe disease. Brain 145(4):1257\u20131263. https:\/\/doi.org\/10.1093\/brain\/awac002","journal-title":"Brain"},{"issue":"10","key":"3060_CR93","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/mds.27802","volume":"34","author":"S Heinzel","year":"2019","unstructured":"Heinzel S, Berg D, Gasser T, Chen H, Yao C, Postuma RB (2019) Update of the MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord 34(10):1464\u20131470. https:\/\/doi.org\/10.1002\/mds.27802","journal-title":"Mov Disord"},{"issue":"6","key":"3060_CR94","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years. Mov Disord 23(6):837\u2013844. https:\/\/doi.org\/10.1002\/mds.21956","journal-title":"Mov Disord"},{"issue":"10","key":"3060_CR95","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s00702-024-02797-9","volume":"131","author":"GU H\u00f6glinger","year":"2024","unstructured":"H\u00f6glinger GU, Lang AE (2024) The why and how of the synnerge criteria of Parkinson s disease. J Neural Transm 131(10):1149\u20131154. https:\/\/doi.org\/10.1007\/s00702-024-02797-9","journal-title":"J Neural Transm"},{"issue":"2","key":"3060_CR96","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","volume":"23","author":"GU H\u00f6glinger","year":"2024","unstructured":"H\u00f6glinger GU, Adler CH, Berg D, Klein C, Outeiro TF, Poewe W, Postuma R, Stoessl AJ, Lang AE (2024) A biological classification of Parkinson\u2019s disease: the synneurge research diagnostic criteria. Lancet Neurol 23(2):191\u2013204. https:\/\/doi.org\/10.1016\/S1474-4422(23)00404-0","journal-title":"Lancet Neurol"},{"key":"3060_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.106101","volume":"122","author":"J Horsager","year":"2024","unstructured":"Horsager J, Borghammer P (2024) Brain-first vs. body-first Parkinson\u2019s disease: an update on recent evidence. Parkinsonism Relat Disord 122:106101. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106101","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"3060_CR98","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1093\/brain\/awaa238","volume":"143","author":"J Horsager","year":"2020","unstructured":"Horsager J, Andersen KB, Knudsen K, Skjaerbaek C, Fedorova TD, Okkels N, Schaeffer E, Bonkat SK, Geday J, Otto M, Sommerauer M, Danielsen EH, Bech E, Kraft J, Munk OL, Hansen SD, Pavese N, Goder R, Brooks DJ, Berg D, Borghammer P (2020a) Brain-first versus body-first parkinson\u2019s disease: a multimodal imaging case-control study. Brain 143(10):3077\u20133088. https:\/\/doi.org\/10.1093\/brain\/awaa238","journal-title":"Brain"},{"issue":"10","key":"3060_CR99","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.parkreldis.2013.05.010","volume":"19","author":"J Horvath","year":"2013","unstructured":"Horvath J, Herrmann FR, Burkhard PR, Bouras C, Kovari E (2013) Neuropathology of dementia in a large cohort of patients with Parkinson\u2019s disease. Parkinsonism Relat Disord 19(10):864\u2013868. https:\/\/doi.org\/10.1016\/j.parkreldis.2013.05.010","journal-title":"Parkinsonism Relat Disord"},{"issue":"14","key":"3060_CR100","doi-asserted-by":"publisher","first-page":"e1855","DOI":"10.1212\/WNL.0000000000011699","volume":"96","author":"E Howard","year":"2021","unstructured":"Howard E, Irwin DJ, Rascovsky K, Nevler N, Shellikeri S, Tropea TF, Spindler M, Deik A, Chen-Plotkin A, Siderowf A, Dahodwala N, Weintraub D, Shaw LM, Trojanowski JQ, Vaishnavi SN, Wolk DA, Mechanic-Hamilton D, Morley JF, Duda JE, Grossman M, Cousins KAQ (2021) Cognitive profile and markers of Alzheimer disease-type pathology in patients with Lewy body dementias. Neurology 96(14):e1855\u2013e1864. https:\/\/doi.org\/10.1212\/WNL.0000000000011699","journal-title":"Neurology"},{"issue":"2","key":"3060_CR101","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1001\/archneur.1993.00540020018011","volume":"50","author":"AJ Hughes","year":"1993","unstructured":"Hughes AJ, Daniel SE, Blankson S, Lees AJ (1993) A clinicopathologic study of 100 cases of Parkinson\u2019s disease. Arch Neurol 50(2):140\u2013148. https:\/\/doi.org\/10.1001\/archneur.1993.00540020018011","journal-title":"Arch Neurol"},{"issue":"10","key":"3060_CR102","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1212\/wnl.54.10.1916","volume":"54","author":"HI Hurtig","year":"2000","unstructured":"Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM, Clark CM, Glosser G, Stern MB, Gollomp SM, Arnold SE (2000) Alpha-synuclein cortical lewy bodies correlate with dementia in parkinson\u2019s disease. Neurology 54(10):1916\u20131921. https:\/\/doi.org\/10.1212\/wnl.54.10.1916","journal-title":"Neurology"},{"issue":"1","key":"3060_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Thies B, Trojanowski JQ, Vinters HV, Montine TJ (2012) National institute on aging-Alzheimer\u2019s association guidelines for the neuropathologic assessment of alzheimer\u2019s disease. Alzheimers Dement 8(1):1\u201313. https:\/\/doi.org\/10.1016\/j.jalz.2011.10.007","journal-title":"Alzheimers Dement"},{"issue":"4","key":"3060_CR104","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/archneur.65.4.514","volume":"65","author":"T Ikeuchi","year":"2008","unstructured":"Ikeuchi T, Kakita A, Shiga A, Kasuga K, Kaneko H, Tan CF, Idezuka J, Wakabayashi K, Onodera O, Iwatsubo T, Nishizawa M, Takahashi H, Ishikawa A (2008) Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia. Arch Neurol 65(4):514\u2013519. https:\/\/doi.org\/10.1001\/archneur.65.4.514","journal-title":"Arch Neurol"},{"issue":"4","key":"3060_CR105","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/ana.23659","volume":"72","author":"DJ Irwin","year":"2012","unstructured":"Irwin DJ, White MT, Toledo JB, Xie SX, Robinson JL, Van Deerlin V, Lee VM, Leverenz JB, Montine TJ, Duda JE, Hurtig HI, Trojanowski JQ (2012) Neuropathologic substrates of Parkinson disease dementia. Ann Neurol 72(4):587\u2013598. https:\/\/doi.org\/10.1002\/ana.23659","journal-title":"Ann Neurol"},{"key":"3060_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3549","author":"DJ Irwin","year":"2013","unstructured":"Irwin DJ, Lee VM, Trojanowski JQ (2013) Parkinson\u2019s disease dementia: convergence of alpha-synuclein, Tau and amyloid-beta pathologies. Nat Rev Neurosci. https:\/\/doi.org\/10.1038\/nrn3549","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"3060_CR107","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","volume":"16","author":"DJ Irwin","year":"2017","unstructured":"Irwin DJ, Grossman M, Weintraub D, Hurtig HI, Duda JE, Xie SX, Lee EB, Van Deerlin VM, Lopez OL, Kofler JK, Nelson PT, Jicha GA, Woltjer R, Quinn JF, Kaye J, Leverenz JB, Tsuang D, Longfellow K, Yearout D, Kukull W, Keene CD, Montine TJ, Zabetian CP, Trojanowski JQ (2017) Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Lancet Neurol 16(1):55\u201365. https:\/\/doi.org\/10.1016\/S1474-4422(16)30291-5","journal-title":"Lancet Neurol"},{"issue":"12","key":"3060_CR108","doi-asserted-by":"publisher","first-page":"e1038","DOI":"10.1212\/WNL.0000000000005166","volume":"90","author":"DJ Irwin","year":"2018","unstructured":"Irwin DJ, Xie SX, Coughlin D, Nevler N, Akhtar RS, McMillan CT, Lee EB, Wolk DA, Weintraub D, Chen-Plotkin A, Duda JE, Spindler M, Siderowf A, Hurtig HI, Shaw LM, Grossman M, Trojanowski JQ (2018) CSF Tau and beta-amyloid predict cerebral synucleinopathy in autopsied lewy body disorders. Neurology 90(12):e1038\u2013e1046. https:\/\/doi.org\/10.1212\/WNL.0000000000005166","journal-title":"Neurology"},{"issue":"3","key":"3060_CR109","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/ana.25811","volume":"88","author":"DJ Irwin","year":"2020","unstructured":"Irwin DJ, Fedler J, Coffey CS, Caspell-Garcia C, Kang JH, Simuni T, Foroud T, Toga AW, Tanner CM, Kieburtz K, Chahine LM, Reimer A, Hutten S, Weintraub D, Mollenhauer B, Galasko DR, Siderowf A, Marek K, Trojanowski JQ, Shaw LM (2020) Parkinson\u2019s progression marker I evolution of Alzheimer\u2019s disease cerebrospinal fluid biomarkers in early Parkinson\u2019s disease. Ann Neurol 88(3):574\u2013587. https:\/\/doi.org\/10.1002\/ana.25811","journal-title":"Ann Neurol"},{"issue":"1","key":"3060_CR110","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1440-1789.2003.00530.x","volume":"24","author":"E Iseki","year":"2004","unstructured":"Iseki E (2004) Dementia with Lewy bodies: reclassification of pathological subtypes and boundary with Parkinson\u2019s disease or Alzheimer\u2019s disease. Neuropathology 24(1):72\u201378. https:\/\/doi.org\/10.1111\/j.1440-1789.2003.00530.x","journal-title":"Neuropathology"},{"issue":"5","key":"3060_CR111","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","volume":"87","author":"CR Jack","year":"2016","unstructured":"Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, Hampel H, Jagust WJ, Johnson KA, Knopman DS, Petersen RC, Scheltens P, Sperling RA, Dubois B (2016) A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology 87(5):539\u2013547. https:\/\/doi.org\/10.1212\/WNL.0000000000002923","journal-title":"Neurology"},{"issue":"8","key":"3060_CR112","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack","year":"2024","unstructured":"Jack CR, Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A, Hansson O, Ho C, Jagust W, McDade E, Molinuevo JL, Okonkwo OC, Pani L, Rafii MS, Scheltens P, Siemers E, Snyder HM, Sperling R, Teunissen CE, Carrillo MC (2024) Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s association workgroup. Alzheimers Dement 20(8):5143\u20135169. https:\/\/doi.org\/10.1002\/alz.13859","journal-title":"Alzheimers Dement"},{"issue":"1","key":"3060_CR113","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/alz.13398","volume":"20","author":"L Jain","year":"2024","unstructured":"Jain L, Khrestian M, Formica S, Tuason ED, Pillai JA, Rao S, Oguh O, Lippa CF, Lopez OL, Berman SB, Tsuang DW, Zabetian CP, Irwin DJ, Galasko DR, Litvan I, Marder KS, Honig LS, Fleisher JE, Galvin JE, Bozoki AC, Taylor AS, Sabbagh MN, Leverenz JB, Bekris LM (2024) ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: initial results from the United States dementia with Lewy bodies consortium. Alzheimers Dement 20(1):549\u2013562. https:\/\/doi.org\/10.1002\/alz.13398","journal-title":"Alzheimers Dement"},{"issue":"10","key":"3060_CR114","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1212\/wnl.40.10.1529","volume":"40","author":"J Jankovic","year":"1990","unstructured":"Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I et al (1990) Variable expression of parkinson\u2019s disease: a base-line analysis of the DATATOP cohort. The Parkinson study group. Neurology 40(10):1529\u20131534. https:\/\/doi.org\/10.1212\/wnl.40.10.1529","journal-title":"Neurology"},{"issue":"10\u201311","key":"3060_CR115","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s00702-004-0138-7","volume":"111","author":"KA Jellinger","year":"2004","unstructured":"Jellinger KA (2004) Lewy body-related alpha-synucleinopathy in the aged human brain. J Neural Transm (Vienna) 111(10\u201311):1219\u20131235. https:\/\/doi.org\/10.1007\/s00702-004-0138-7","journal-title":"J Neural Transm (Vienna)"},{"key":"3060_CR116","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-3-211-73574-9_12","volume":"72","author":"KA Jellinger","year":"2007","unstructured":"Jellinger KA (2007) Morphological substrates of parkinsonism with and without dementia: a retrospective clinico-pathological study. J Neural Transm Suppl 72:91\u2013104. https:\/\/doi.org\/10.1007\/978-3-211-73574-9_12","journal-title":"J Neural Transm Suppl"},{"issue":"1","key":"3060_CR117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-008-0406-y","volume":"116","author":"KA Jellinger","year":"2008","unstructured":"Jellinger KA (2008) A critical reappraisal of current staging of Lewy-related pathology in human brain. Acta Neuropathol 116(1):1\u201316. https:\/\/doi.org\/10.1007\/s00401-008-0406-y","journal-title":"Acta Neuropathol"},{"issue":"5","key":"3060_CR118","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3233\/JPD-240174","volume":"14","author":"KA Jellinger","year":"2024","unstructured":"Jellinger KA (2024) Parkinson\u2019s disease and dementia with lewy bodies: one and the same? J Parkinsons Dis 14(5):1071\u20131072. https:\/\/doi.org\/10.3233\/JPD-240174","journal-title":"J Parkinsons Dis"},{"issue":"4","key":"3060_CR119","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00401-008-0347-5","volume":"115","author":"KA Jellinger","year":"2008","unstructured":"Jellinger KA, Attems J (2008) Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Acta Neuropathol 115(4):427\u2013436. https:\/\/doi.org\/10.1007\/s00401-008-0347-5","journal-title":"Acta Neuropathol"},{"issue":"1","key":"3060_CR120","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1016-8","volume":"16","author":"KA Jellinger","year":"2018","unstructured":"Jellinger KA, Korczyn AD (2018) Are dementia with lewy bodies and Parkinson\u2019s disease dementia the same disease? BMC Med 16(1):34. https:\/\/doi.org\/10.1186\/s12916-018-1016-8","journal-title":"BMC Med"},{"issue":"3","key":"3060_CR121","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s007020200027","volume":"109","author":"KA Jellinger","year":"2002","unstructured":"Jellinger KA, Seppi K, Wenning GK, Poewe W (2002) Impact of coexistent Alzheimer pathology on the natural history of Parkinson\u2019s disease. J Neural Transm (Vienna) 109(3):329\u2013339. https:\/\/doi.org\/10.1007\/s007020200027","journal-title":"J Neural Transm (Vienna)"},{"issue":"5","key":"3060_CR122","doi-asserted-by":"publisher","first-page":"e70205","DOI":"10.1002\/alz.70205","volume":"21","author":"EM Jonaitis","year":"2025","unstructured":"Jonaitis EM, MacLeod K, Lamoureux J, Jeffers B, Studer RL, Middleton J, Wilson RE, Chin NA, Okonkwo OC, Bendlin BB, Asthana S, Carlsson CM, Gallagher CL, Hermann B, McEvoy S, Kollmorgen G, Zetterberg H, Concha-Marambio L, Johnson SC, Lebovitz RM, Langhough RE (2025) Misfolded alpha-synuclein co-occurrence with alzheimer\u2019s disease proteinopathy. Alzheimers Dement 21(5):e70205. https:\/\/doi.org\/10.1002\/alz.70205","journal-title":"Alzheimers Dement"},{"issue":"8","key":"3060_CR123","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1093\/brain\/awad072","volume":"146","author":"S Joza","year":"2023","unstructured":"Joza S, Hu MT, Jung KY, Kunz D, Stefani A, Dusek P, Terzaghi M, Arnaldi D, Videnovic A, Schiess MC, Hermann W, Lee JY, Ferini-Strambi L, Lewis SJG, Leclair-Visonneau L, Oertel WH, Antelmi E, Sixel-Doring F, Cochen De Cock V, Liguori C, Liu J, Provini F, Puligheddu M, Nicoletti A, Bassetti CLA, Buskova J, Dauvilliers Y, Ferri R, Montplaisir JY, Lawton M, Kim HJ, Bes F, Hogl B, Sonka K, Fiamingo G, Mattioli P, Lavadia ML, Suescun J, Woo KA, Marelli S, Martens KE, Janzen A, Plazzi G, Mollenhauer B, Fernandes M, Li Y, Cortelli P, Figorilli M, Cicero CE, Schaefer C, Guiraud L, Lanza G, Gagnon JF, Sunwoo JS, Ibrahim A, Girtler N, Trenkwalder C, Baldelli L, Pelletier A, Postuma RB, International REMSBDSG (2023) Progression of clinical markers in prodromal parkinson\u2019s disease and dementia with lewy bodies: a multicentre study. Brain 146(8):3258\u20133272. https:\/\/doi.org\/10.1093\/brain\/awad072","journal-title":"Brain"},{"issue":"1","key":"3060_CR124","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/alz.13386","volume":"20","author":"S Joza","year":"2024","unstructured":"Joza S, Hu MT, Jung KY, Kunz D, Arnaldi D, Lee JY, Ferini-Strambi L, Antelmi E, Sixel-Doring F, De Cock VC, Montplaisir JY, Welch J, Kim HJ, Bes F, Mattioli P, Woo KA, Marelli S, Plazzi G, Mollenhauer B, Pelletier A, Razzaque J, Sunwoo JS, Girtler N, Trenkwalder C, Gagnon JF, Postuma RB, International REMSBDSG (2024) Prodromal dementia with lewy bodies in REM sleep behavior disorder: A multicenter study. Alzheimers Dement 20(1):91\u2013102. https:\/\/doi.org\/10.1002\/alz.13386","journal-title":"Alzheimers Dement"},{"issue":"5","key":"3060_CR125","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1093\/brain\/awab402","volume":"145","author":"K Kaivola","year":"2022","unstructured":"Kaivola K, Shah Z, Chia R, International LBDGC, Scholz SW (2022) Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups. Brain 145(5):1757\u20131762. https:\/\/doi.org\/10.1093\/brain\/awab402","journal-title":"Brain"},{"issue":"2","key":"3060_CR126","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/NEN.0b013e31816362aa","volume":"67","author":"ME Kalaitzakis","year":"2008","unstructured":"Kalaitzakis ME, Graeber MB, Gentleman SM, Pearce RK (2008) Striatal beta-amyloid deposition in Parkinson disease with dementia. J Neuropathol Exp Neurol 67(2):155\u2013161. https:\/\/doi.org\/10.1097\/NEN.0b013e31816362aa","journal-title":"J Neuropathol Exp Neurol"},{"key":"3060_CR127","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.3861","author":"JH Kang","year":"2013","unstructured":"Kang JH, Irwin DJ, Chen-Plotkin A, Siderowf A, Caspell C, Coffey CS, Waligorska T, Taylor P, Pan S, Frasier M, Marek K, Kieburtz K, Jennings D, Simuni T, Tanner CM, Singleton AB, Toga AW, Chowdhury S, Mollenhauer B, Trojanowski JQ, Shaw L, Parkinson Progression Marker I (2013) Association of cerebrospinal fluid A\u03b21\u201342, t-tau, p-tau181 and \u03b1-synuclein levels with clinical features of early drug na\u00efve Parkinson\u2019s disease patients. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2013.3861","journal-title":"JAMA Neurol"},{"issue":"1","key":"3060_CR128","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/ana.24825","volume":"81","author":"K Kantarci","year":"2017","unstructured":"Kantarci K, Lowe VJ, Boeve BF, Senjem ML, Tosakulwong N, Lesnick TG, Spychalla AJ, Gunter JL, Fields JA, Graff-Radford J, Ferman TJ, Jones DT, Murray ME, Knopman DS, Jack CR Jr., Petersen RC (2017) AV-1451 Tau and beta-amyloid positron emission tomography imaging in dementia with lewy bodies. Ann Neurol 81(1):58\u201367. https:\/\/doi.org\/10.1002\/ana.24825","journal-title":"Ann Neurol"},{"issue":"Pt 6","key":"3060_CR129","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1093\/brain\/awq059","volume":"133","author":"PA Kempster","year":"2010","unstructured":"Kempster PA, O\u2019Sullivan SS, Holton JL, Revesz T, Lees AJ (2010) Relationships between age and late progression of parkinson\u2019s disease: a clinico-pathological study. Brain 133(Pt 6):1755\u20131762. https:\/\/doi.org\/10.1093\/brain\/awq059","journal-title":"Brain"},{"issue":"7","key":"3060_CR130","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S1474-4422(24)00217-5","volume":"23","author":"FB Ketchum","year":"2024","unstructured":"Ketchum FB, Chin NA (2024) Concerns with the new biological research criteria for synucleinopathy. Lancet Neurol 23(7):659. https:\/\/doi.org\/10.1016\/S1474-4422(24)00217-5","journal-title":"Lancet Neurol"},{"issue":"4","key":"3060_CR131","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, Lee JH, Kim WR, Kook M, Foss CA, Shen C, Lee H, Kulkarni S, Pasricha PJ, Lee G, Pomper MG, Dawson VL, Dawson TM, Ko HS (2019) Transneuronal propagation of pathologic alpha-Synuclein from the gut to the brain models parkinson\u2019s disease. Neuron 103(4):627\u2013641e627. https:\/\/doi.org\/10.1016\/j.neuron.2019.05.035","journal-title":"Neuron"},{"issue":"3","key":"3060_CR132","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang GF, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langstrom B (2004) Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B. Ann Neurol 55(3):306\u2013319. https:\/\/doi.org\/10.1002\/ana.20009","journal-title":"Ann Neurol"},{"issue":"4","key":"3060_CR133","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00401-021-02364-6","volume":"142","author":"EH Kok","year":"2021","unstructured":"Kok EH, Savola S, Raunio A, Oinas M, Tuimala J, Polvikoski T, Kero M, Kaivola K, Tienari PJ, Paetau A, Myllykangas L (2021) Alpha-synuclein pathology of olfactory bulbs\/peduncles in the Vantaa85\u2009+\u2009cohort exhibit two divergent patterns: a population-based study. Acta Neuropathol 142(4):777\u2013780. https:\/\/doi.org\/10.1007\/s00401-021-02364-6","journal-title":"Acta Neuropathol"},{"issue":"3","key":"3060_CR134","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/BF00685366","volume":"36","author":"K Kosaka","year":"1976","unstructured":"Kosaka K, Oyanagi S, Matsushita M, Hori A (1976) Presenile dementia with Alzheimer-, Pick- and Lewy-body changes. Acta Neuropathol 36(3):221\u2013233. https:\/\/doi.org\/10.1007\/BF00685366","journal-title":"Acta Neuropathol"},{"issue":"10","key":"3060_CR135","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1001\/archneurol.2012.1608","volume":"69","author":"PT Kotzbauer","year":"2012","unstructured":"Kotzbauer PT, Cairns NJ, Campbell MC, Willis AW, Racette BA, Tabbal SD, Perlmutter JS (2012) Pathologic accumulation of alpha-synuclein and Abeta in Parkinson disease patients with dementia. Arch Neurol 69(10):1326\u20131331. https:\/\/doi.org\/10.1001\/archneurol.2012.1608","journal-title":"Arch Neurol"},{"issue":"1","key":"3060_CR136","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00401-003-0705-2","volume":"106","author":"E Kovari","year":"2003","unstructured":"Kovari E, Gold G, Herrmann FR, Canuto A, Hof PR, Bouras C, Giannakopoulos P (2003) Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson\u2019s disease. Acta Neuropathol 106(1):83\u201388. https:\/\/doi.org\/10.1007\/s00401-003-0705-2","journal-title":"Acta Neuropathol"},{"issue":"12","key":"3060_CR137","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1212\/01.WNL.0000165987.89198.65","volume":"64","author":"ML Kraybill","year":"2005","unstructured":"Kraybill ML, Larson EB, Tsuang DW, Teri L, McCormick WC, Bowen JD, Kukull WA, Leverenz JB, Cherrier MM (2005) Cognitive differences in dementia patients with autopsy-verified AD, lewy body pathology, or both. Neurology 64(12):2069\u20132073. https:\/\/doi.org\/10.1212\/01.WNL.0000165987.89198.65","journal-title":"Neurology"},{"issue":"7","key":"3060_CR138","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/s1474-4422(24)00212-6","volume":"23","author":"AE Lang","year":"2024","unstructured":"Lang AE, H\u00f6glinger GU, Adler CH, Berg D, Klein C, Outeiro TF, Poewe W, Postuma R, Stoessl AJ (2024) Concerns with the new biological research criteria for synucleinopathy \u2013 Authors\u2019 reply. Lancet Neurol 23(7):666\u2013668. https:\/\/doi.org\/10.1016\/s1474-4422(24)00212-6","journal-title":"Lancet Neurol"},{"issue":"4","key":"3060_CR139","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00401-007-0336-0","volume":"115","author":"T Lashley","year":"2008","unstructured":"Lashley T, Holton JL, Gray E, Kirkham K, O\u2019Sullivan SS, Hilbig A, Wood NW, Lees AJ, Revesz T (2008) Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of parkinson\u2019s disease patients. Acta Neuropathol 115(4):417\u2013425. https:\/\/doi.org\/10.1007\/s00401-007-0336-0","journal-title":"Acta Neuropathol"},{"issue":"14","key":"3060_CR140","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adt7195","volume":"11","author":"HA Lashuel","year":"2025","unstructured":"Lashuel HA, Surmeier DJ, Simuni T, Merchant K, Caughey B, Soto C, Fares MB, Heym RG, Melki R (2025) Alpha-synuclein seed amplification assays: data sharing, standardization needed for clinical use. Sci Adv 11(14):eadt7195. https:\/\/doi.org\/10.1126\/sciadv.adt7195","journal-title":"Sci Adv"},{"issue":"3","key":"3060_CR141","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.tins.2004.01.007","volume":"27","author":"VM Lee","year":"2004","unstructured":"Lee VM, Giasson BI, Trojanowski JQ (2004) More than just two peas in a pod: common amyloidogenic properties of Tau and alpha-synuclein in neurodegenerative diseases. Trends Neurosci 27(3):129\u2013134. https:\/\/doi.org\/10.1016\/j.tins.2004.01.007","journal-title":"Trends Neurosci"},{"issue":"2","key":"3060_CR142","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/jnnp-2016-313775","volume":"88","author":"AW Lemstra","year":"2017","unstructured":"Lemstra AW, de Beer MH, Teunissen CE, Schreuder C, Scheltens P, van der Flier WM, Sikkes SA (2017) Concomitant AD pathology affects clinical manifestation and survival in dementia with lewy bodies. J Neurol Neurosurg Psychiatry 88(2):113\u2013118. https:\/\/doi.org\/10.1136\/jnnp-2016-313775","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"3060_CR143","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1001\/archneur.63.3.370","volume":"63","author":"JB Leverenz","year":"2006","unstructured":"Leverenz JB, Fishel MA, Peskind ER, Montine TJ, Nochlin D, Steinbart E, Raskind MA, Schellenberg GD, Bird TD, Tsuang D (2006) Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype. Arch Neurol 63(3):370\u2013376. https:\/\/doi.org\/10.1001\/archneur.63.3.370","journal-title":"Arch Neurol"},{"issue":"2","key":"3060_CR144","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1750-3639.2007.00117.x","volume":"18","author":"JB Leverenz","year":"2008","unstructured":"Leverenz JB, Hamilton R, Tsuang DW, Schantz A, Vavrek D, Larson EB, Kukull WA, Lopez O, Galasko D, Masliah E, Kaye J, Woltjer R, Clark C, Trojanowski JQ, Montine TJ (2008) Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient. Brain Pathol 18(2):220\u2013224. https:\/\/doi.org\/10.1111\/j.1750-3639.2007.00117.x","journal-title":"Brain Pathol"},{"issue":"5","key":"3060_CR145","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/s0002-9440(10)65722-7","volume":"153","author":"CF Lippa","year":"1998","unstructured":"Lippa CF, Fujiwara H, Mann DM, Giasson B, Baba M, Schmidt ML, Nee LE, O\u2019Connell B, Pollen DA, St George-Hyslop P, Ghetti B, Nochlin D, Bird TD, Cairns NJ, Lee VM, Iwatsubo T, Trojanowski JQ (1998) Lewy bodies contain altered alpha-synuclein in brains of many Familial alzheimer\u2019s disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 153(5):1365\u20131370. https:\/\/doi.org\/10.1016\/s0002-9440(10)65722-7","journal-title":"Am J Pathol"},{"issue":"3","key":"3060_CR146","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/1531-8249(199903)45:3<353::aid-ana11>3.0.co;2-4","volume":"45","author":"CF Lippa","year":"1999","unstructured":"Lippa CF, Schmidt ML, Lee VM, Trojanowski JQ (1999) Antibodies to alpha-synuclein detect lewy bodies in many down\u2019s syndrome brains with alzheimer\u2019s disease. Ann Neurol 45(3):353\u2013357. https:\/\/doi.org\/10.1002\/1531-8249(199903)45:3%3C353::aid-ana11%3E3.0.co;2-4","journal-title":"Ann Neurol"},{"issue":"11","key":"3060_CR147","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1212\/01.wnl.0000256715.13907.d3","volume":"68","author":"CF Lippa","year":"2007","unstructured":"Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM, Galasko D, Galvin JE, Goetz CG, Growdon JH, Gwinn-Hardy KA, Hardy J, Heutink P, Iwatsubo T, Kosaka K, Lee VM, Leverenz JB, Masliah E, McKeith IG, Nussbaum RL, Olanow CW, Ravina BM, Singleton AB, Tanner CM, Trojanowski JQ, Wszolek ZK, Group DPW (2007) DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology 68(11):812\u2013819. https:\/\/doi.org\/10.1212\/01.wnl.0000256715.13907.d3","journal-title":"Neurology"},{"issue":"7","key":"3060_CR148","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/archneur.55.7.969","volume":"55","author":"I Litvan","year":"1998","unstructured":"Litvan I, MacIntyre A, Goetz CG, Wenning GK, Jellinger K, Verny M, Bartko JJ, Jankovic J, McKee A, Brandel JP, Chaudhuri KR, Lai EC, D\u2019Olhaberriague L, Pearce RK, Agid Y (1998) Accuracy of the clinical diagnoses of lewy body disease, Parkinson disease, and dementia with lewy bodies: a clinicopathologic study. Arch Neurol 55(7):969\u2013978. https:\/\/doi.org\/10.1001\/archneur.55.7.969","journal-title":"Arch Neurol"},{"issue":"3","key":"3060_CR149","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.24893","volume":"27","author":"I Litvan","year":"2012","unstructured":"Litvan I, Goldman JG, Troster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M (2012) Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: movement disorder society task force guidelines. Mov Disord 27(3):349\u2013356. https:\/\/doi.org\/10.1002\/mds.24893","journal-title":"Mov Disord"},{"issue":"11","key":"3060_CR150","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1001\/archneurol.2009.221","volume":"66","author":"RY Lo","year":"2009","unstructured":"Lo RY, Tanner CM, Albers KB, Leimpeter AD, Fross RD, Bernstein AL, McGuire V, Quesenberry CP, Nelson LM, Van Den Eeden SK (2009) Clinical features in early Parkinson disease and survival. Arch Neurol 66(11):1353\u20131358. https:\/\/doi.org\/10.1001\/archneurol.2009.221","journal-title":"Arch Neurol"},{"issue":"6","key":"3060_CR151","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1212\/wnl.53.6.1292","volume":"53","author":"OL Lopez","year":"1999","unstructured":"Lopez OL, Litvan I, Catt KE, Stowe R, Klunk W, Kaufer DI, Becker JT, DeKosky ST (1999) Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias. Neurology 53(6):1292\u20131299. https:\/\/doi.org\/10.1212\/wnl.53.6.1292","journal-title":"Neurology"},{"issue":"4","key":"3060_CR152","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1212\/01.wnl.0000230161.28299.3c","volume":"67","author":"OL Lopez","year":"2006","unstructured":"Lopez OL, Becker JT, Sweet RA, Martin-Sanchez FJ, Hamilton RL (2006) Lewy bodies in the amygdala increase risk for major depression in subjects with Alzheimer disease. Neurology 67(4):660\u2013665. https:\/\/doi.org\/10.1212\/01.wnl.0000230161.28299.3c","journal-title":"Neurology"},{"issue":"47","key":"3060_CR153","doi-asserted-by":"publisher","first-page":"20051","DOI":"10.1073\/pnas.0908005106","volume":"106","author":"KC Luk","year":"2009","unstructured":"Luk KC, Song C, O\u2019Brien P, Stieber A, Branch JR, Brunden KR, Trojanowski JQ, Lee VM (2009) Exogenous alpha-synuclein fibrils seed the formation of lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci U S A 106(47):20051\u201320056. https:\/\/doi.org\/10.1073\/pnas.0908005106","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6109","key":"3060_CR154","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm V, Carroll J, Zhang B, O\u2019Brien P, Trojanowski JQ, Lee VM (2012a) Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338(6109):949\u2013953. https:\/\/doi.org\/10.1126\/science.1227157","journal-title":"Science"},{"issue":"5","key":"3060_CR155","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1084\/jem.20112457","volume":"209","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm VM, Zhang B, O\u2019Brien P, Trojanowski JQ, Lee VM (2012b) Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J Exp Med 209(5):975\u2013986. https:\/\/doi.org\/10.1084\/jem.20112457","journal-title":"J Exp Med"},{"issue":"1","key":"3060_CR156","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ymgme.2003.11.004","volume":"81","author":"A Lwin","year":"2004","unstructured":"Lwin A, Orvisky E, Goker-Alpan O, LaMarca ME, Sidransky E (2004) Glucocerebrosidase mutations in subjects with parkinsonism. Mol Genet Metab 81(1):70\u201373. https:\/\/doi.org\/10.1016\/j.ymgme.2003.11.004","journal-title":"Mol Genet Metab"},{"issue":"9","key":"3060_CR157","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1002\/mds.28651","volume":"36","author":"A Mammana","year":"2021","unstructured":"Mammana A, Baiardi S, Quadalti C, Rossi M, Donadio V, Capellari S, Liguori R, Parchi P (2021) <scp>RT\u2010QuIC<\/scp>Detection of Pathological \u03b1\u2010Synuclein in Skin Punches of Patients with Lewy Body Disease. Mov Disord 36(9):2173\u20132177. https:\/\/doi.org\/10.1002\/mds.28651","journal-title":"Mov Disord"},{"issue":"12","key":"3060_CR158","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1002\/mds.28242","volume":"35","author":"S Manne","year":"2020","unstructured":"Manne S, Kondru N, Jin H, Serrano GE, Anantharam V, Kanthasamy A, Adler CH, Beach TG, Kanthasamy AG (2020) Blinded RT-QuIC analysis of alpha-Synuclein biomarker in skin tissue from parkinson\u2019s disease patients. Mov Disord 35(12):2230\u20132239. https:\/\/doi.org\/10.1002\/mds.28242","journal-title":"Mov Disord"},{"issue":"1","key":"3060_CR159","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/ana.26542","volume":"93","author":"WRW Martin","year":"2023","unstructured":"Martin WRW, Younce JR, Campbell MC, Racette BA, Norris SA, Ushe M, Criswell S, Davis AA, Alfradique-Dunham I, Maiti B, Cairns NJ, Perrin RJ, Kotzbauer PT, Perlmutter JS (2023) Neocortical lewy body pathology parallels parkinson\u2019s Dementia, but not always. Ann Neurol 93(1):184\u2013195. https:\/\/doi.org\/10.1002\/ana.26542","journal-title":"Ann Neurol"},{"issue":"1","key":"3060_CR160","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49402-x","volume":"15","author":"SE Mastenbroek","year":"2024","unstructured":"Mastenbroek SE, Vogel JW, Collij LE, Serrano GE, Tremblay C, Young AL, Arce RA, Shill HA, Driver-Dunckley ED, Mehta SH, Belden CM, Atri A, Choudhury P, Barkhof F, Adler CH, Ossenkoppele R, Beach TG, Hansson O (2024) Disease progression modelling reveals heterogeneity in trajectories of Lewy-type \u03b1-synuclein pathology. Nat Commun 15(1):5133. https:\/\/doi.org\/10.1038\/s41467-024-49402-x","journal-title":"Nat Commun"},{"issue":"1","key":"3060_CR161","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1038\/s41467-025-62458-7","volume":"16","author":"SE Mastenbroek","year":"2025","unstructured":"Mastenbroek SE, Collij LE, Vogel JW, Caldera S, Serrano GE, Adler CH, Vargiu CM, Palmqvist S, Barkhof F, Parchi P, Beach TG, Ossenkoppele R, Hansson O (2025) Two-step detection of lewy body pathology via smell-function testing and CSF alpha-synuclein seed amplification. Nat Commun 16(1):7182. https:\/\/doi.org\/10.1038\/s41467-025-62458-7","journal-title":"Nat Commun"},{"issue":"1","key":"3060_CR162","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/mds.26359","volume":"31","author":"IF Mata","year":"2016","unstructured":"Mata IF, Leverenz JB, Weintraub D, Trojanowski JQ, Chen-Plotkin A, Van Deerlin VM, Ritz B, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson-Hiller AL, Goldman JG, Stebbins GT, Bernard B, Espay AJ, Revilla FJ, Devoto J, Rosenthal LS, Dawson TM, Albert MS, Tsuang D, Huston H, Yearout D, Hu SC, Cholerton BA, Montine TJ, Edwards KL, Zabetian CP (2016) GBA variants are associated with a distinct pattern of cognitive deficits in parkinson\u2019s disease. Mov Disord 31(1):95\u2013102. https:\/\/doi.org\/10.1002\/mds.26359","journal-title":"Mov Disord"},{"issue":"3","key":"3060_CR163","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s004019900168","volume":"100","author":"PM Mattila","year":"2000","unstructured":"Mattila PM, Rinne JO, Helenius H, Dickson DW, Roytta M (2000) Alpha-synuclein-immunoreactive cortical lewy bodies are associated with cognitive impairment in Parkinson\u2019s disease. Acta Neuropathol 100(3):285\u2013290. https:\/\/doi.org\/10.1007\/s004019900168","journal-title":"Acta Neuropathol"},{"issue":"12","key":"3060_CR164","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S1474-4422(24)00402-2","volume":"23","author":"G Maya","year":"2024","unstructured":"Maya G, Iranzo A, Gaig C, Sanchez-Valle R, Serradell M, Molina-Porcel L, Santamaria J, Gelpi E, Aldecoa I (2024) Post-mortem neuropathology of idiopathic rapid eye movement sleep behaviour disorder: a case series. Lancet Neurol 23(12):1238\u20131251. https:\/\/doi.org\/10.1016\/S1474-4422(24)00402-2","journal-title":"Lancet Neurol"},{"issue":"4","key":"3060_CR165","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1017\/s0033291700038484","volume":"22","author":"IG McKeith","year":"1992","unstructured":"McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK (1992) Operational criteria for senile dementia of lewy body type (SDLT). Psychol Med 22(4):911\u2013922. https:\/\/doi.org\/10.1017\/s0033291700038484","journal-title":"Psychol Med"},{"issue":"5","key":"3060_CR166","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1212\/wnl.47.5.1113","volume":"47","author":"IG McKeith","year":"1996","unstructured":"McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen ENH, Ballard C, Vos RAI, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with lewy bodies (DLB). Neurology 47(5):1113\u20131124. https:\/\/doi.org\/10.1212\/wnl.47.5.1113","journal-title":"Neurology"},{"issue":"5","key":"3060_CR167","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1212\/wnl.53.5.902","volume":"53","author":"IG McKeith","year":"1999","unstructured":"McKeith IG, Perry EK, Perry RH, Consortium on Dementia with Lewy Bodies (1999) Report of the second dementia with lewy body international workshop: diagnosis and treatment. Neurology 53(5):902\u2013905. https:\/\/doi.org\/10.1212\/wnl.53.5.902","journal-title":"Neurology"},{"issue":"12","key":"3060_CR168","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O\u2019Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M, Consortium on DLB (2005) Diagnosis and management of dementia with lewy bodies: third report of the DLB consortium. Neurology 65(12):1863\u20131872. https:\/\/doi.org\/10.1212\/01.wnl.0000187889.17253.b1","journal-title":"Neurology"},{"issue":"1","key":"3060_CR169","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O\u2019Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K (2017) Diagnosis and management of dementia with lewy bodies: fourth consensus report of the DLB consortium. Neurology 89(1):88\u2013100. https:\/\/doi.org\/10.1212\/WNL.0000000000004058","journal-title":"Neurology"},{"issue":"17","key":"3060_CR170","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","volume":"94","author":"IG McKeith","year":"2020","unstructured":"McKeith IG, Ferman TJ, Thomas AJ, Blanc F, Boeve BF, Fujishiro H, Kantarci K, Muscio C, O\u2019Brien JT, Postuma RB, Aarsland D, Ballard C, Bonanni L, Donaghy P, Emre M, Galvin JE, Galasko D, Goldman JG, Gomperts SN, Honig LS, Ikeda M, Leverenz JB, Lewis SJG, Marder KS, Masellis M, Salmon DP, Taylor JP, Tsuang DW, Walker Z, Tiraboschi P (2020) prodromal DLBDSG Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology 94(17):743\u2013755. https:\/\/doi.org\/10.1212\/WNL.0000000000009323","journal-title":"Neurology"},{"key":"3060_CR171","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Kawas RJJC, Klunk CH, Koroshetz WE, Manly WJ, Mayeux JJ, Mohs R, Morris RC, Rossor JC, Scheltens MN, Carrillo P, Thies MC, Weintraub BS, Phelps CH (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7:263\u2013269. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005","journal-title":"Alzheimers Dement"},{"issue":"10","key":"3060_CR172","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1212\/01.wnl.0000065889.42856.f2","volume":"60","author":"AR Merdes","year":"2003","unstructured":"Merdes AR, Hansen LA, Jeste DV, Galasko D, Hofstetter CR, Ho GJ, Thal LJ, Corey-Bloom J (2003) Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology 60(10):1586\u20131590. https:\/\/doi.org\/10.1212\/01.wnl.0000065889.42856.f2","journal-title":"Neurology"},{"issue":"9","key":"3060_CR173","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1136\/jnnp.2004.052332","volume":"76","author":"S Molloy","year":"2005","unstructured":"Molloy S, McKeith IG, O\u2019Brien JT, Burn DJ (2005) The role of Levodopa in the management of dementia with lewy bodies. J Neurol Neurosurg Psychiatry 76(9):1200\u20131203. https:\/\/doi.org\/10.1136\/jnnp.2004.052332","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"3060_CR174","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1212\/01.wnl.0000180516.69442.95","volume":"65","author":"D Muslimovic","year":"2005","unstructured":"Muslimovic D, Post B, Speelman JD, Schmand B (2005) Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 65(8):1239\u20131245. https:\/\/doi.org\/10.1212\/01.wnl.0000180516.69442.95","journal-title":"Neurology"},{"issue":"3","key":"3060_CR175","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00401-007-0261-2","volume":"114","author":"H Nakashima-Yasuda","year":"2007","unstructured":"Nakashima-Yasuda H, Uryu K, Robinson J, Xie SX, Hurtig H, Duda JE, Arnold SE, Siderowf A, Grossman M, Leverenz JB, Woltjer R, Lopez OL, Hamilton R, Tsuang DW, Galasko D, Masliah E, Kaye J, Clark CM, Montine TJ, Lee VM, Trojanowski JQ (2007) Co-morbidity of TDP-43 proteinopathy in lewy body related diseases. Acta Neuropathol 114(3):221\u2013229. https:\/\/doi.org\/10.1007\/s00401-007-0261-2","journal-title":"Acta Neuropathol"},{"issue":"1","key":"3060_CR176","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.neurobiolaging.2014.07.005","volume":"36","author":"Z Nedelska","year":"2015","unstructured":"Nedelska Z, Ferman TJ, Boeve BF, Przybelski SA, Lesnick TG, Murray ME, Gunter JL, Senjem ML, Vemuri P, Smith GE, Geda YE, Graff-Radford J, Knopman DS, Petersen RC, Parisi JE, Dickson DW, Jack CR Jr., Kantarci K (2015) Pattern of brain atrophy rates in autopsy-confirmed dementia with lewy bodies. Neurobiol Aging 36(1):452\u2013461. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.07.005","journal-title":"Neurobiol Aging"},{"issue":"11","key":"3060_CR177","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1007\/s00415-010-5630-4","volume":"257","author":"PT Nelson","year":"2010","unstructured":"Nelson PT, Schmitt FA, Jicha GA, Kryscio RJ, Abner EL, Smith CD, Van Eldik LJ, Markesbery WR (2010) Association between male gender and cortical lewy body pathology in large autopsy series. J Neurol 257(11):1875\u20131881. https:\/\/doi.org\/10.1007\/s00415-010-5630-4","journal-title":"J Neurol"},{"issue":"1","key":"3060_CR178","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/jnen\/nlx099","volume":"77","author":"PT Nelson","year":"2018","unstructured":"Nelson PT, Abner EL, Patel E, Anderson S, Wilcock DM, Kryscio RJ, Van Eldik LJ, Jicha GA, Gal Z, Nelson RS, Nelson BG, Gal J, Azam MT, Fardo DW, Cykowski MD (2018) The amygdala as a locus of pathologic misfolding in neurodegenerative diseases. J Neuropathol Exp Neurol 77(1):2\u201320. https:\/\/doi.org\/10.1093\/jnen\/nlx099","journal-title":"J Neuropathol Exp Neurol"},{"key":"3060_CR179","doi-asserted-by":"publisher","DOI":"10.3310\/pgfar09070","author":"JT O\u2019Brien","year":"2021","unstructured":"O\u2019Brien JT, Taylor JP, Thomas A, Bamford C, Vale L, Hill S, Allan L, Finch T, McNally R, Hayes L, Surendranathan A, Kane J, Chrysos AE, Bentley A, Barker S, Mason J, Burn D, McKeith I (2021) Improving the diagnosis and management of Lewy body dementia: the DIAMOND-Lewy research programme including pilot cluster RCT. Programme Grants Appl Res. https:\/\/doi.org\/10.3310\/pgfar09070","journal-title":"Programme Grants Appl Res"},{"issue":"6","key":"3060_CR180","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00401-005-0995-7","volume":"109","author":"S Orimo","year":"2005","unstructured":"Orimo S, Amino T, Itoh Y, Takahashi A, Kojo T, Uchihara T, Tsuchiya K, Mori F, Wakabayashi K, Takahashi H (2005) Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in lewy body disease. Acta Neuropathol 109(6):583\u2013588. https:\/\/doi.org\/10.1007\/s00401-005-0995-7","journal-title":"Acta Neuropathol"},{"issue":"1","key":"3060_CR181","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-025-01944-x","volume":"13","author":"M Otero-Jimenez","year":"2025","unstructured":"Otero-Jimenez M, Wojewska MJ, Binding LP, Jogaudaite S, Gray-Rodriguez S, Young AL, Gentleman S, Alegre-Abarrategui J (2025) Neuropathological stages of neuronal, astrocytic and oligodendrocytic alpha-synuclein pathology in Parkinson\u2019s disease. Acta Neuropathol Commun 13(1):25. https:\/\/doi.org\/10.1186\/s40478-025-01944-x","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"3060_CR182","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/mds.26432","volume":"31","author":"J Pagonabarraga","year":"2016","unstructured":"Pagonabarraga J, Martinez-Horta S, Fernandez de Bobadilla R, Perez J, Ribosa-Nogue R, Marin J, Pascual-Sedano B, Garcia C, Gironell A, Kulisevsky J (2016) Minor hallucinations occur in drug-naive parkinson\u2019s disease patients, even from the premotor phase. Mov Disord 31(1):45\u201352. https:\/\/doi.org\/10.1002\/mds.26432","journal-title":"Mov Disord"},{"issue":"8","key":"3060_CR183","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/s41591-023-02450-0","volume":"29","author":"S Palmqvist","year":"2023","unstructured":"Palmqvist S, Rossi M, Hall S, Quadalti C, Mattsson-Carlgren N, Dellavalle S, Tideman P, Pereira JB, Nilsson MH, Mammana A, Janelidze S, Baiardi S, Stomrud E, Parchi P, Hansson O (2023) Cognitive effects of lewy body pathology in clinically unimpaired individuals. Nat Med 29(8):1971\u20131978. https:\/\/doi.org\/10.1038\/s41591-023-02450-0","journal-title":"Nat Med"},{"issue":"1","key":"3060_CR184","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/ana.20321","volume":"57","author":"L Parkkinen","year":"2005","unstructured":"Parkkinen L, Kauppinen T, Pirttila T, Autere JM, Alafuzoff I (2005) Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia. Ann Neurol 57(1):82\u201391. https:\/\/doi.org\/10.1002\/ana.20321","journal-title":"Ann Neurol"},{"key":"3060_CR185","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.parkreldis.2016.07.008","volume":"31","author":"GM Peavy","year":"2016","unstructured":"Peavy GM, Edland SD, Toole BM, Hansen LA, Galasko DR, Mayo AM (2016) Phenotypic differences based on staging of Alzheimer\u2019s neuropathology in autopsy-confirmed dementia with Lewy bodies. Parkinsonism Relat Disord 31:72\u201378. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.07.008","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"3060_CR186","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1136\/jnnp.48.5.413","volume":"48","author":"EK Perry","year":"1985","unstructured":"Perry EK, Curtis M, Dick DJ, Candy JM, Atack JR, Bloxham CA, Blessed G, Fairbairn A, Tomlinson BE, Perry RH (1985) Cholinergic correlates of cognitive impairment in Parkinson\u2019s disease: comparisons with Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 48(5):413\u2013421. https:\/\/doi.org\/10.1136\/jnnp.48.5.413","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"3060_CR187","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0022-510x(90)90236-g","volume":"95","author":"RH Perry","year":"1990","unstructured":"Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK (1990) Senile dementia of lewy body type. A clinically and neuropathologically distinct form of lewy body dementia in the elderly. J Neurol Sci 95(2):119\u2013139. https:\/\/doi.org\/10.1016\/0022-510x(90)90236-g","journal-title":"J Neurol Sci"},{"issue":"12","key":"3060_CR188","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1001\/jamaneurol.2023.3664","volume":"80","author":"RC Petersen","year":"2023","unstructured":"Petersen RC, Weintraub S, Sabbagh M, Karlawish J, Adler CH, Dilworth-Anderson P, Frank L, Huling Hummel C, Taylor A, Dementia Nomenclature I (2023) A new framework for dementia nomenclature. JAMA Neurol 80(12):1364\u20131370. https:\/\/doi.org\/10.1001\/jamaneurol.2023.3664","journal-title":"JAMA Neurol"},{"issue":"5321","key":"3060_CR189","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with parkinson\u2019s disease. Science 276(5321):2045\u20132047. https:\/\/doi.org\/10.1126\/science.276.5321.2045","journal-title":"Science"},{"issue":"12","key":"3060_CR190","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1001\/archneur.61.12.1915","volume":"61","author":"A Popescu","year":"2004","unstructured":"Popescu A, Lippa CF, Lee VM, Trojanowski JQ (2004) Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions. Arch Neurol 61(12):1915\u20131919. https:\/\/doi.org\/10.1001\/archneur.61.12.1915","journal-title":"Arch Neurol"},{"issue":"7 Suppl 1","key":"3060_CR191","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1212\/WNL.0000000000200235","volume":"99","author":"RB Postuma","year":"2022","unstructured":"Postuma RB (2022) Neuroprotective trials in REM sleep behavior disorder: the way forward becomes clearer. Neurology 99(7 Suppl 1):19\u201325. https:\/\/doi.org\/10.1212\/WNL.0000000000200235","journal-title":"Neurology"},{"issue":"6","key":"3060_CR192","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1212\/01.wnl.0000203648.80727.5b","volume":"66","author":"RB Postuma","year":"2006","unstructured":"Postuma RB, Lang AE, Massicotte-Marquez J, Montplaisir J (2006) Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology 66(6):845\u2013851. https:\/\/doi.org\/10.1212\/01.wnl.0000203648.80727.5b","journal-title":"Neurology"},{"issue":"12","key":"3060_CR193","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"issue":"3","key":"3060_CR194","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/brain\/awz030","volume":"142","author":"RB Postuma","year":"2019","unstructured":"Postuma RB, Iranzo A, Hu M, Hogl B, Boeve BF, Manni R, Oertel WH, Arnulf I, Ferini-Strambi L, Puligheddu M, Antelmi E, Cochen De Cock V, Arnaldi D, Mollenhauer B, Videnovic A, Sonka K, Jung KY, Kunz D, Dauvilliers Y, Provini F, Lewis SJ, Buskova J, Pavlova M, Heidbreder A, Montplaisir JY, Santamaria J, Barber TR, Stefani A, St Louis EK, Terzaghi M, Janzen A, Leu-Semenescu S, Plazzi G, Nobili F, Sixel-Doering F, Dusek P, Bes F, Cortelli P, Ehgoetz Martens K, Gagnon JF, Gaig C, Zucconi M, Trenkwalder C, Gan-Or Z, Lo C, Rolinski M, Mahlknecht P, Holzknecht E, Boeve AR, Teigen LN, Toscano G, Mayer G, Morbelli S, Dawson B, Pelletier A (2019) Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain 142(3):744\u2013759. https:\/\/doi.org\/10.1093\/brain\/awz030","journal-title":"Brain"},{"issue":"8","key":"3060_CR195","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1038\/s41591-023-02449-7","volume":"29","author":"C Quadalti","year":"2023","unstructured":"Quadalti C, Palmqvist S, Hall S, Rossi M, Mammana A, Janelidze S, Dellavalle S, Mattsson-Carlgren N, Baiardi S, Stomrud E, Hansson O, Parchi P (2023) Clinical effects of lewy body pathology in cognitively impaired individuals. Nat Med 29(8):1964\u20131970. https:\/\/doi.org\/10.1038\/s41591-023-02449-7","journal-title":"Nat Med"},{"issue":"9","key":"3060_CR196","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1002\/mds.29144","volume":"37","author":"P Reho","year":"2022","unstructured":"Reho P, Koga S, Shah Z, Chia R, International LBDGC, American Genome C, Rademakers R, Dalgard CL, Boeve BF, Beach TG, Dickson DW, Ross OA, Scholz SW (2022) GRN mutations are associated with Lewy body dementia. Mov Disord 37(9):1943\u20131948. https:\/\/doi.org\/10.1002\/mds.29144","journal-title":"Mov Disord"},{"issue":"7","key":"3060_CR197","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1474-4422(24)00215-1","volume":"23","author":"J Reis","year":"2024","unstructured":"Reis J, Tranchant C, Lucchini RG, Spencer PS (2024) Concerns with the new biological research criteria for synucleinopathy. Lancet Neurol 23(7):663. https:\/\/doi.org\/10.1016\/S1474-4422(24)00215-1","journal-title":"Lancet Neurol"},{"issue":"6","key":"3060_CR198","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1002\/mds.10274","volume":"17","author":"IH Richard","year":"2002","unstructured":"Richard IH, Papka M, Rubio A, Kurlan R (2002) Parkinson\u2019s disease and dementia with lewy bodies: one disease or two? Mov Disord 17(6):1161\u20131165. https:\/\/doi.org\/10.1002\/mds.10274","journal-title":"Mov Disord"},{"key":"3060_CR199","doi-asserted-by":"publisher","unstructured":"Rizig M, Bandres-Ciga S, Makarious MB, Ojo OO, Crea PW, Abiodun OV, Levine KS, Abubakar SA, Achoru CO, Vitale D, Adeniji OA, Agabi OP, Koretsky MJ, Agulanna U, Hall DA, Akinyemi RO, Xie T, Ali MW, Shamim EA, Ani-Osheku I, Padmanaban M, Arigbodi OM, Standaert DG, Bello AH, Dean MN, Erameh CO, Elsayed I, Farombi TH, Okunoye O, Fawale MB, Billingsley KJ, Imarhiagbe FA, Jerez PA, Iwuozo EU, Baker B, Komolafe MA, Malik L, Nwani PO, Daida K, Nwazor EO, Miano-Burkhardt A, Nyandaiti YW, Fang ZH, Obiabo YO, Kluss JH, Odeniyi OA, Hernandez DG, Odiase FE, Tayebi N, Ojini FI, Sidranksy E, Onwuegbuzie GA, D\u2019Souza AM, Osaigbovo GO, Berhe B, Osemwegie N, Reed X, Oshinaike OO, Leonard HL, Otubogun FM, Alvarado CX, Oyakhire SI, Ozomma SI, Samuel SC, Taiwo FT, Wahab KW, Zubair YA, Iwaki H, Kim JJ, Morris HR, Hardy J, Nalls MA, Heilbron K, Norcliffe-Kaufmann L, Nigeria Parkinson Disease Research N, International Parkinson\u2019s Disease Genomics Consortium A, Black, African American Connections to Parkinson\u2019s Disease Study, andMe Research G, Blauwendraat T, Houlden C, Singleton H, Okubadejo A (2023) NU, Global Parkinson\u2019s Genetics P Identification of genetic risk loci and causal insights associated with Parkinson\u2019s disease in African and African admixed populations: a genome-wide association study. Lancet Neurol 22 (11):1015\u20131025. https:\/\/doi.org\/10.1016\/S1474-4422(23)00283-1","DOI":"10.1016\/S1474-4422(23)00283-1"},{"issue":"6","key":"3060_CR200","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1093\/brain\/awad059","volume":"146","author":"JL Robinson","year":"2023","unstructured":"Robinson JL, Xie SX, Baer DR, Suh E, Van Deerlin VM, Loh NJ, Irwin DJ, McMillan CT, Wolk DA, Chen-Plotkin A, Weintraub D, Schuck T, Lee VMY, Trojanowski JQ, Lee EB (2023) Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated. Brain 146(6):2557\u20132569. https:\/\/doi.org\/10.1093\/brain\/awad059","journal-title":"Brain"},{"issue":"1","key":"3060_CR201","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-022-00299-w","volume":"11","author":"F Rodriguez-Porcel","year":"2022","unstructured":"Rodriguez-Porcel F, Wyman-Chick KA, Abdelnour Ruiz C, Toledo JB, Ferreira D, Urwyler P, Weil RS, Kane J, Pilotto A, Rongve A, Boeve B, Taylor JP, McKeith I, Aarsland D, Lewis SJG (2022) Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations. Transl Neurodegener 11(1):24. https:\/\/doi.org\/10.1186\/s40035-022-00299-w","journal-title":"Transl Neurodegener"},{"issue":"9","key":"3060_CR202","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/mds.23073","volume":"25","author":"E Rosenthal","year":"2010","unstructured":"Rosenthal E, Brennan L, Xie S, Hurtig H, Milber J, Weintraub D, Karlawish J, Siderowf A (2010) Association between cognition and function in patients with Parkinson disease with and without dementia. Mov Disord 25(9):1170\u20131176. https:\/\/doi.org\/10.1002\/mds.23073","journal-title":"Mov Disord"},{"issue":"3","key":"3060_CR203","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3233\/JAD-201187","volume":"80","author":"SG Ryman","year":"2021","unstructured":"Ryman SG, Yutsis M, Tian L, Henderson VW, Montine TJ, Salmon DP, Galasko D, Poston KL (2021) Cognition at each stage of lewy body disease with co-occurring Alzheimer\u2019s disease pathology. J Alzheimers Dis 80(3):1243\u20131256. https:\/\/doi.org\/10.3233\/JAD-201187","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"3060_CR204","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/WAD.0b013e31819c5ef4","volume":"23","author":"MN Sabbagh","year":"2009","unstructured":"Sabbagh MN, Adler CH, Lahti TJ, Connor DJ, Vedders L, Peterson LK, Caviness JN, Shill HA, Sue LI, Ziabreva I, Perry E, Ballard CG, Aarsland D, Walker DG, Beach TG (2009) Parkinson disease with dementia: comparing patients with and without Alzheimer pathology. Alzheimer Dis Assoc Disord 23(3):295\u2013297. https:\/\/doi.org\/10.1097\/WAD.0b013e31819c5ef4","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"1","key":"3060_CR205","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/ane.13028","volume":"139","author":"R Savica","year":"2019","unstructured":"Savica R, Beach TG, Hentz JG, Sabbagh MN, Serrano GE, Sue LI, Dugger BN, Shill HA, Driver-Dunckley E, Caviness JN, Mehta SH, Jacobson SA, Belden CM, Davis KJ, Zamrini E, Shprecher DR, Adler CH (2019) Lewy body pathology in Alzheimer\u2019s disease: a clinicopathological prospective study. Acta Neurol Scand 139(1):76\u201381. https:\/\/doi.org\/10.1111\/ane.13028","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"3060_CR206","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1212\/wnl.46.2.388","volume":"46","author":"CH Schenck","year":"1996","unstructured":"Schenck CH, Bundlie SR, Mahowald MW (1996) Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 46(2):388\u2013393. https:\/\/doi.org\/10.1212\/wnl.46.2.388","journal-title":"Neurology"},{"issue":"24","key":"3060_CR207","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","volume":"69","author":"JA Schneider","year":"2007","unstructured":"Schneider JA, Arvanitakis Z, Bang W, Bennett DA (2007) Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69(24):2197\u20132204. https:\/\/doi.org\/10.1212\/01.wnl.0000271090.28148.24","journal-title":"Neurology"},{"issue":"2","key":"3060_CR208","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/ana.21706","volume":"66","author":"JA Schneider","year":"2009","unstructured":"Schneider JA, Arvanitakis Z, Leurgans SE, Bennett DA (2009) The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol 66(2):200\u2013208. https:\/\/doi.org\/10.1002\/ana.21706","journal-title":"Ann Neurol"},{"key":"3060_CR209","doi-asserted-by":"publisher","unstructured":"Scott GD, Arnold MR, Beach TG, Gibbons CH, Kanthasamy AG, Lebovitz RM, Lemstra AW, Shaw LM, Teunissen CE, Zetterberg H, Taylor AS, Graham TC, Boeve BF, Gomperts SN, Graff-Radford NR, Moussa C, Poston KL, Rosenthal LS, Sabbagh MN, Walsh RR, Weber MT, Armstrong MJ, Bang JA, Bozoki AC, Domoto-Reilly K, Duda JE, Fleisher JE, Galasko DR, Galvin JE, Goldman JG, Holden SK, Honig LS, Huddleston DE, Leverenz JB, Litvan I, Manning CA, Marder KS, Pantelyat AY, Pelak VS, Scharre DW, Sha SJ, Shill HA, Mari Z, Quinn JF, Irwin DJ (2021) Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium. Front Neurol 12:805135. https:\/\/doi.org\/10.3389\/fneur.2021.805135","DOI":"10.3389\/fneur.2021.805135"},{"issue":"1","key":"3060_CR210","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00401-025-02872-9","volume":"149","author":"H Sekiya","year":"2025","unstructured":"Sekiya H, Franke L, Hashimoto Y, Takata M, Nishida K, Futamura N, Hasegawa K, Kowa H, Ross OA, McLean PJ, Toda T, Wszolek ZK, Dickson DW (2025) Widespread distribution of alpha-synuclein oligomers in LRRK2-related parkinson\u2019s disease. Acta Neuropathol 149(1):42. https:\/\/doi.org\/10.1007\/s00401-025-02872-9","journal-title":"Acta Neuropathol"},{"issue":"8 Suppl 3","key":"3060_CR211","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1212\/wnl.63.8_suppl_3.s31","volume":"63","author":"C Serrano","year":"2004","unstructured":"Serrano C, Garcia-Borreguero D (2004) Fluctuations in cognition and alertness in parkinson\u2019s disease and dementia. Neurology 63(8 Suppl 3):S31\u201334. https:\/\/doi.org\/10.1212\/wnl.63.8_suppl_3.s31","journal-title":"Neurology"},{"issue":"5","key":"3060_CR212","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00401-011-0808-0","volume":"121","author":"LM Shaw","year":"2011","unstructured":"Shaw LM, Vanderstichele H, Knapik-Czajka M, Figurski M, Coart E, Blennow K, Soares H, Simon AJ, Lewczuk P, Dean RA, Siemers E, Potter W, Lee VM, Trojanowski JQ, Alzheimer\u2019s Disease Neuroimaging I (2011) Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI. Acta Neuropathol 121(5):597\u2013609. https:\/\/doi.org\/10.1007\/s00401-011-0808-0","journal-title":"Acta Neuropathol"},{"key":"3060_CR213","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.parkreldis.2022.07.023","volume":"102","author":"S Shellikeri","year":"2022","unstructured":"Shellikeri S, Cho S, Cousins KAQ, Liberman M, Howard E, Balganorth Y, Weintraub D, Spindler M, Deik A, Lee EB, Trojanowski JQ, Irwin D, Wolk D, Grossman M, Nevler N (2022) Natural speech markers of Alzheimer\u2019s disease co-pathology in lewy body dementias. Parkinsonism Relat Disord 102:94\u2013100. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.07.023","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"3060_CR214","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1212\/WNL.0b013e3181f39a78","volume":"75","author":"A Siderowf","year":"2010","unstructured":"Siderowf A, Xie SX, Hurtig H, Weintraub D, Duda J, Chen-Plotkin A, Shaw LM, Van Deerlin V, Trojanowski JQ, Clark C (2010) CSF amyloid {beta} 1\u201342 predicts cognitive decline in Parkinson disease. Neurology 75(12):1055\u20131061. https:\/\/doi.org\/10.1212\/WNL.0b013e3181f39a78","journal-title":"Neurology"},{"key":"3060_CR215","doi-asserted-by":"publisher","unstructured":"Siderowf A, Concha-Marambio L, Lafontant DE, Farris CM, Ma Y, Urenia PA, Nguyen H, Alcalay RN, Chahine LM, Foroud T, Galasko D, Kieburtz K, Merchant K, Mollenhauer B, Poston KL, Seibyl J, Simuni T, Tanner CM, Weintraub D, Videnovic A, Choi SH, Kurth R, Caspell-Garcia C, Coffey CS, Frasier M, Oliveira LMA, Hutten SJ, Sherer T, Marek K, Soto C (2023) Parkinson\u2019s Progression Markers I Assessment of heterogeneity among participants in the Parkinson\u2019s Progression Markers Initiative cohort using alpha-synuclein seed amplification: a cross-sectional study. Lancet Neurol 22 (5):407\u2013417. https:\/\/doi.org\/10.1016\/S1474-4422(23)00109-6","DOI":"10.1016\/S1474-4422(23)00109-6"},{"issue":"11","key":"3060_CR216","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","volume":"11","author":"E Sidransky","year":"2012","unstructured":"Sidransky E, Lopez G (2012) The link between the GBA gene and parkinsonism. Lancet Neurol 11(11):986\u2013998. https:\/\/doi.org\/10.1016\/S1474-4422(12)70190-4","journal-title":"Lancet Neurol"},{"issue":"17","key":"3060_CR217","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER, Bar-Shira A, Berg D, Bras J, Brice A, Chen CM, Clark LN, Condroyer C, De Marco EV, Durr A, Eblan MJ, Fahn S, Farrer MJ, Fung HC, Gan-Or Z, Gasser T, Gershoni-Baruch R, Giladi N, Griffith A, Gurevich T, Januario C, Kropp P, Lang AE, Lee-Chen GJ, Lesage S, Marder K, Mata IF, Mirelman A, Mitsui J, Mizuta I, Nicoletti G, Oliveira C, Ottman R, Orr-Urtreger A, Pereira LV, Quattrone A, Rogaeva E, Rolfs A, Rosenbaum H, Rozenberg R, Samii A, Samaddar T, Schulte C, Sharma M, Singleton A, Spitz M, Tan EK, Tayebi N, Toda T, Troiano AR, Tsuji S, Wittstock M, Wolfsberg TG, Wu YR, Zabetian CP, Zhao Y, Ziegler SG (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease. N Engl J Med 361(17):1651\u20131661. https:\/\/doi.org\/10.1056\/NEJMoa0901281","journal-title":"N Engl J Med"},{"issue":"2","key":"3060_CR218","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","volume":"23","author":"T Simuni","year":"2024","unstructured":"Simuni T, Chahine LM, Poston K, Brumm M, Buracchio T, Campbell M, Chowdhury S, Coffey C, Concha-Marambio L, Dam T, DiBiaso P, Foroud T, Frasier M, Gochanour C, Jennings D, Kieburtz K, Kopil CM, Merchant K, Mollenhauer B, Montine T, Nudelman K, Pagano G, Seibyl J, Sherer T, Singleton A, Stephenson D, Stern M, Soto C, Tanner CM, Tolosa E, Weintraub D, Xiao Y, Siderowf A, Dunn B, Marek K (2024a) A biological definition of neuronal alpha-synuclein disease: towards an integrated staging system for research. Lancet Neurol 23(2):178\u2013190. https:\/\/doi.org\/10.1016\/S1474-4422(23)00405-2","journal-title":"Lancet Neurol"},{"issue":"7","key":"3060_CR219","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/s1474-4422(24)00233-3","volume":"23","author":"T Simuni","year":"2024","unstructured":"Simuni T, Chahine LM, Weintraub D, Poston KM, Kopil CM, Dunn B, Marek K (2024c) Concerns with the new biological research criteria for synucleinopathy \u2013 authors\u2019 reply. Lancet Neurol 23(7):663\u2013666. https:\/\/doi.org\/10.1016\/s1474-4422(24)00233-3","journal-title":"Lancet Neurol"},{"issue":"5646","key":"3060_CR220","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K (2003) alpha-Synuclein locus triplication causes parkinson\u2019s disease. Science 302(5646):841. https:\/\/doi.org\/10.1126\/science.1090278","journal-title":"Science"},{"issue":"4","key":"3060_CR221","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3233\/JAD-170274","volume":"59","author":"R Skogseth","year":"2017","unstructured":"Skogseth R, Hortobagyi T, Soennesyn H, Chwiszczuk L, Ffytche D, Rongve A, Ballard C, Aarsland D (2017) Accuracy of clinical diagnosis of dementia with lewy bodies versus neuropathology. J Alzheimers Dis 59(4):1139\u20131152. https:\/\/doi.org\/10.3233\/JAD-170274","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"3060_CR222","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1136\/jnnp-2019-321111","volume":"90","author":"C Smith","year":"2019","unstructured":"Smith C, Malek N, Grosset K, Cullen B, Gentleman S, Grosset DG (2019) Neuropathology of dementia in patients with parkinson\u2019s disease: a systematic review of autopsy studies. J Neurol Neurosurg Psychiatry 90(11):1234\u20131243. https:\/\/doi.org\/10.1136\/jnnp-2019-321111","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"3060_CR223","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s40478-019-0787-2","volume":"7","author":"ZA Sorrentino","year":"2019","unstructured":"Sorrentino ZA, Goodwin MS, Riffe CJ, Dhillon JS, Xia Y, Gorion KM, Vijayaraghavan N, McFarland KN, Golbe LI, Yachnis AT, Giasson BI (2019) Unique alpha-synuclein pathology within the amygdala in lewy body dementia: implications for disease initiation and progression. Acta Neuropathol Commun 7(1):142. https:\/\/doi.org\/10.1186\/s40478-019-0787-2","journal-title":"Acta Neuropathol Commun"},{"issue":"6645","key":"3060_CR224","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in lewy bodies. Nature 388(6645):839\u2013840. https:\/\/doi.org\/10.1038\/42166","journal-title":"Nature"},{"issue":"12","key":"3060_CR225","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1002\/acn3.51183","volume":"7","author":"N Spotorno","year":"2020","unstructured":"Spotorno N, Coughlin DG, Olm CA, Wolk D, Vaishnavi SN, Shaw LM, Dahodwala N, Morley JF, Duda JE, Deik AF, Spindler MA, Chen-Plotkin A, Lee EB, Trojanowski JQ, McMillan CT, Weintraub D, Grossman M, Irwin DJ (2020) Tau pathology associates with in vivo cortical thinning in lewy body disorders. Ann Clin Transl Neurol 7(12):2342\u20132355. https:\/\/doi.org\/10.1002\/acn3.51183","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"3060_CR226","doi-asserted-by":"publisher","first-page":"108351","DOI":"10.1016\/j.jbc.2025.108351","volume":"301","author":"C Sun","year":"2025","unstructured":"Sun C, Zhou K, DePaola P, Li C, Lee VMY, Zhou ZH, Peng C, Jiang L (2025) Structural basis of a distinct alpha-synuclein strain that promotes Tau inclusion in neurons. J Biol Chem 301(4):108351. https:\/\/doi.org\/10.1016\/j.jbc.2025.108351","journal-title":"J Biol Chem"},{"issue":"2","key":"3060_CR227","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","volume":"18","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier DJ, Obeso JA, Halliday GM (2017) Selective neuronal vulnerability in Parkinson disease. Nat Rev Neurosci 18(2):101\u2013113. https:\/\/doi.org\/10.1038\/nrn.2016.178","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"3060_CR228","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/mds.870110216","volume":"11","author":"A Tan","year":"1996","unstructured":"Tan A, Salgado M, Fahn S (1996) Rapid eye movement sleep behavior disorder preceding Parkinson\u2019s disease with therapeutic response to levodopa. Mov Disord 11(2):214\u2013216. https:\/\/doi.org\/10.1002\/mds.870110216","journal-title":"Mov Disord"},{"issue":"2","key":"3060_CR229","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/s1096-7192(03)00071-4","volume":"79","author":"N Tayebi","year":"2003","unstructured":"Tayebi N, Walker J, Stubblefield B, Orvisky E, LaMarca ME, Wong K, Rosenbaum H, Schiffmann R, Bembi B, Sidransky E (2003) Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab 79(2):104\u2013109. https:\/\/doi.org\/10.1016\/s1096-7192(03)00071-4","journal-title":"Mol Genet Metab"},{"issue":"2","key":"3060_CR230","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(19)30153-X","volume":"19","author":"JP Taylor","year":"2020","unstructured":"Taylor JP, McKeith IG, Burn DJ, Boeve BF, Weintraub D, Bamford C, Allan LM, Thomas AJ, O\u2019Brien JT (2020) New evidence on the management of lewy body dementia. Lancet Neurol 19(2):157\u2013169. https:\/\/doi.org\/10.1016\/S1474-4422(19)30153-X","journal-title":"Lancet Neurol"},{"issue":"3","key":"3060_CR231","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1212\/WNL.0000000000003512","volume":"88","author":"AJ Thomas","year":"2017","unstructured":"Thomas AJ, Attems J, Colloby SJ, O\u2019Brien JT, McKeith I, Walker R, Lee L, Burn D, Lett DJ, Walker Z (2017) Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB. Neurology 88(3):276\u2013283. https:\/\/doi.org\/10.1212\/WNL.0000000000003512","journal-title":"Neurology"},{"issue":"3","key":"3060_CR232","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00401-015-1526-9","volume":"131","author":"JB Toledo","year":"2016","unstructured":"Toledo JB, Gopal P, Raible K, Irwin DJ, Brettschneider J, Sedor S, Waits K, Boluda S, Grossman M, Van Deerlin VM, Lee EB, Arnold SE, Duda JE, Hurtig H, Lee VM, Adler CH, Beach TG, Trojanowski JQ (2016) Pathological alpha-synuclein distribution in subjects with coincident alzheimer\u2019s and lewy body pathology. Acta Neuropathol 131(3):393\u2013409. https:\/\/doi.org\/10.1007\/s00401-015-1526-9","journal-title":"Acta Neuropathol"},{"issue":"1","key":"3060_CR233","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/alz.12814","volume":"19","author":"JB Toledo","year":"2023","unstructured":"Toledo JB, Abdelnour C, Weil RS, Ferreira D, Rodriguez-Porcel F, Pilotto A, Wyman-Chick KA, Grothe MJ, Kane JPM, Taylor A, Rongve A, Scholz S, Leverenz JB, Boeve BF, Aarsland D, McKeith IG, Lewis S, Leroi I, Taylor JP, Group ILbdTMW (2023) Dementia with lewy bodies: impact of co-pathologies and implications for clinical trial design. Alzheimers Dement 19(1):318\u2013332. https:\/\/doi.org\/10.1002\/alz.12814","journal-title":"Alzheimers Dement"},{"issue":"8","key":"3060_CR234","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.1002\/alz.13858","volume":"20","author":"D Tosun","year":"2024","unstructured":"Tosun D, Hausle Z, Iwaki H, Thropp P, Lamoureux J, Lee EB, MacLeod K, McEvoy S, Nalls M, Perrin RJ, Saykin AJ, Shaw LM, Singleton AB, Lebovitz R, Weiner MW, Blauwendraat C, Alzheimer\u2019s Disease Neuroimaging I (2024) A cross-sectional study of alpha-synuclein seed amplification assay in alzheimer\u2019s disease neuroimaging initiative: prevalence and associations with alzheimer\u2019s disease biomarkers and cognitive function. Alzheimers Dement 20(8):5114\u20135131. https:\/\/doi.org\/10.1002\/alz.13858","journal-title":"Alzheimers Dement"},{"issue":"5","key":"3060_CR235","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1002\/ana.26635","volume":"93","author":"TF Tropea","year":"2023","unstructured":"Tropea TF, Albuja I, Cousins KAQ, Irwin DJ, Lee EB, Chen-Plotkin AS (2023) Concomitant Alzheimer disease pathology in Parkinson disease dementia. Ann Neurol 93(5):1045\u20131046. https:\/\/doi.org\/10.1002\/ana.26635","journal-title":"Ann Neurol"},{"issue":"19","key":"3060_CR236","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1212\/WNL.0b013e3182735e9a","volume":"79","author":"D Tsuang","year":"2012","unstructured":"Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA, Kramer P, Woltjer R, Kukull W, Nelson PT, Jicha GA, Neltner JH, Galasko D, Masliah E, Trojanowski JQ, Schellenberg GD, Yearout D, Huston H, Fritts-Penniman A, Mata IF, Wan JY, Edwards KL, Montine TJ, Zabetian CP (2012) GBA mutations increase risk for lewy body disease with and without Alzheimer disease pathology. Neurology 79(19):1944\u20131950. https:\/\/doi.org\/10.1212\/WNL.0b013e3182735e9a","journal-title":"Neurology"},{"issue":"2","key":"3060_CR237","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1001\/jamaneurol.2013.600","volume":"70","author":"D Tsuang","year":"2013","unstructured":"Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA, Kramer P, Woltjer R, Trojanowski JQ, Weintraub D, Chen-Plotkin AS, Irwin DJ, Rick J, Schellenberg GD, Watson GS, Kukull W, Nelson PT, Jicha GA, Neltner JH, Galasko D, Masliah E, Quinn JF, Chung KA, Yearout D, Mata IF, Wan JY, Edwards KL, Montine TJ, Zabetian CP (2013) APOE epsilon4 increases risk for dementia in pure synucleinopathies. JAMA Neurol 70(2):223\u2013228. https:\/\/doi.org\/10.1001\/jamaneurol.2013.600","journal-title":"JAMA Neurol"},{"issue":"7","key":"3060_CR238","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1097\/01.jnen.0000225908.90052.07","volume":"65","author":"H Uchikado","year":"2006","unstructured":"Uchikado H, Lin WL, DeLucia MW, Dickson DW (2006) Alzheimer disease with amygdala lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 65(7):685\u2013697. https:\/\/doi.org\/10.1097\/01.jnen.0000225908.90052.07","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"3060_CR239","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1212\/wnl.45.4.709","volume":"45","author":"M Uchiyama","year":"1995","unstructured":"Uchiyama M, Isse K, Tanaka K, Yokota N, Hamamoto M, Aida S, Ito Y, Yoshimura M, Okawa M (1995) Incidental lewy body disease in a patient with REM sleep behavior disorder. Neurology 45(4):709\u2013712. https:\/\/doi.org\/10.1212\/wnl.45.4.709","journal-title":"Neurology"},{"issue":"1","key":"3060_CR240","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00401-021-02383-3","volume":"143","author":"MT Uemura","year":"2022","unstructured":"Uemura MT, Robinson JL, Cousins KAQ, Tropea TF, Kargilis DC, McBride JD, Suh E, Xie SX, Xu Y, Porta S, Uemura N, Van Deerlin VM, Wolk DA, Irwin DJ, Brunden KR, Lee VM, Lee EB, Trojanowski JQ (2022) Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in lewy body disease. Acta Neuropathol 143(1):15\u201331. https:\/\/doi.org\/10.1007\/s00401-021-02383-3","journal-title":"Acta Neuropathol"},{"issue":"12","key":"3060_CR241","doi-asserted-by":"publisher","first-page":"e1262","DOI":"10.1212\/WNL.0000000000200048","volume":"98","author":"M van de Beek","year":"2022","unstructured":"van de Beek M, Ooms FAH, Ebenau JL, Barkhof F, Scheltens P, Teunissen CE, van Harten AC, van der Flier WM, Lemstra AW (2022) Association of the ATN research framework with clinical profile, cognitive decline, and mortality in patients with dementia with lewy bodies. Neurology 98(12):e1262\u2013e1272. https:\/\/doi.org\/10.1212\/WNL.0000000000200048","journal-title":"Neurology"},{"issue":"1","key":"3060_CR242","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley LA, Luk KC, Patel TP, Tanik SA, Riddle DM, Stieber A, Meaney DF, Trojanowski JQ, Lee VM (2011) Exogenous alpha-synuclein fibrils induce lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72(1):57\u201371. https:\/\/doi.org\/10.1016\/j.neuron.2011.08.033","journal-title":"Neuron"},{"issue":"5","key":"3060_CR243","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00401-015-1406-3","volume":"129","author":"L Walker","year":"2015","unstructured":"Walker L, McAleese KE, Thomas AJ, Johnson M, Martin-Ruiz C, Parker C, Colloby SJ, Jellinger K, Attems J (2015) Neuropathologically mixed Alzheimer\u2019s and lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes. Acta Neuropathol 129(5):729\u2013748. https:\/\/doi.org\/10.1007\/s00401-015-1406-3","journal-title":"Acta Neuropathol"},{"key":"3060_CR244","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.parkreldis.2022.05.022","volume":"100","author":"IM Walker","year":"2022","unstructured":"Walker IM, Cousins KA, Siderowf A, Duda JE, Morley JF, Dahodwala N, Tropea T, Vaishnavi S, Wolk DA, Chen-Plotkin AS, Shaw LM, Lee EB, Trojanowski JQ, Grossman M, Weintraub D, Irwin DJ (2022) Non-tremor motor dysfunction in lewy body dementias is associated with AD biomarkers. Parkinsonism Relat Disord 100:33\u201336. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.05.022","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"3060_CR245","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-023-01714-7","volume":"12","author":"L Walker","year":"2024","unstructured":"Walker L, Simpson H, Thomas AJ, Attems J (2024) Prevalence, distribution, and severity of cerebral amyloid angiopathy differ between lewy body diseases and Alzheimer\u2019s disease. Acta Neuropathol Commun 12(1):28. https:\/\/doi.org\/10.1186\/s40478-023-01714-7","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"3060_CR246","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.3233\/JPD-212989","volume":"12","author":"S Weinshel","year":"2022","unstructured":"Weinshel S, Irwin DJ, Zhang P, Weintraub D, Shaw LM, Siderowf A, Xie SX (2022) Appropriateness of applying cerebrospinal fluid biomarker cutoffs from Alzheimer\u2019s disease to Parkinson\u2019s disease. J Parkinsons Dis 12(4):1155\u20131167. https:\/\/doi.org\/10.3233\/JPD-212989","journal-title":"J Parkinsons Dis"},{"issue":"8","key":"3060_CR247","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70312","volume":"21","author":"S Weintraub","year":"2025","unstructured":"Weintraub S, Gefen T, Geula C, Mesulam MM (2025) The first 25 years of the Northwestern University Superaging Program. Alzheimers Dement 21(8):e70312. https:\/\/doi.org\/10.1002\/alz.70312","journal-title":"Alzheimers Dement"},{"issue":"6","key":"3060_CR248","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/mds.29005","volume":"37","author":"GK Wenning","year":"2022","unstructured":"Wenning GK, Stankovic I, Vignatelli L, Fanciulli A, Calandra-Buonaura G, Seppi K, Palma JA, Meissner WG, Krismer F, Berg D, Cortelli P, Freeman R, Halliday G, H\u00f6glinger G, Lang A, Ling H, Litvan I, Low P, Miki Y, Panicker J, Pellecchia MT, Quinn N, Sakakibara R, Stamelou M, Tolosa E, Tsuji S, Warner T, Poewe W, Kaufmann H (2022) The movement disorder society criteria for the diagnosis of multiple system atrophy. Mov Disord 37(6):1131\u20131148. https:\/\/doi.org\/10.1002\/mds.29005","journal-title":"Mov Disord"},{"issue":"3","key":"3060_CR249","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/ana.410130304","volume":"13","author":"PJ Whitehouse","year":"1983","unstructured":"Whitehouse PJ, Hedreen JC, White CL 3rd, Price DL (1983) Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol 13(3):243\u2013248. https:\/\/doi.org\/10.1002\/ana.410130304","journal-title":"Ann Neurol"},{"issue":"4","key":"3060_CR250","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/jnnp-2011-301413","volume":"83","author":"C Wider","year":"2012","unstructured":"Wider C, Ross OA, Nishioka K, Heckman MG, Vilarino-Guell C, Jasinska-Myga B, Erketin-Taner N, Rademakers R, Graff-Radford NR, Mash DC, Papapetropoulos S, Duara R, Uchikado H, Wszolek ZK, Farrer MJ, Dickson DW (2012) An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer\u2019s and Lewy body pathology. J Neurol Neurosurg Psychiatry 83(4):424\u2013429. https:\/\/doi.org\/10.1136\/jnnp-2011-301413","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3060_CR251","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/00005072-196207000-00012","volume":"21","author":"JS Woodard","year":"1962","unstructured":"Woodard JS (1962) Concentric hyaline inclusion body formation in mental disease analysis of twenty-seven cases. J Neuropathol Exp Neurol 21:442\u2013449. https:\/\/doi.org\/10.1097\/00005072-196207000-00012","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"3060_CR252","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atares B, Llorens V, Gomez Tortosa E, del Ser T, Munoz DG, de Yebenes JG (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and lewy body dementia. Ann Neurol 55(2):164\u2013173. https:\/\/doi.org\/10.1002\/ana.10795","journal-title":"Ann Neurol"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-03060-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-025-03060-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-03060-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T13:20:01Z","timestamp":1769692801000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-025-03060-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":252,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["3060"],"URL":"https:\/\/doi.org\/10.1007\/s00702-025-03060-5","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Reference citation has been updated in the text from Hngoglinger and Lang 2024 to H\u00f6glinger and Lang 2024","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DJI receives research funding from the National Institutes of Health, Michael J. Fox Foundation and Lewy body dementia association (LBDA); research funding paid to the institution for clinical trials by Alector, Cervo Med, Denali, Passage Bio and Prevail. DJI is the scientific advisory board chair-elect for the LBDA (unpaid) and on the medical advisory board for the association for frontotemporal degeneration (unpaid).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}